WPRIM Management System> DCMS> China Oncology> 2006> 0

Volume: 0

1. Retrospective analysis of patients with survival of over ten years after resection of esophageal cancer Page:—
2. Paclitaxel plus carboplatin or cisplatin for patients with advanccd head and ncck cancer Page:—
3. Advances in the relationship betreen tumor and venous thromboembolism Page:—
4. Advances in research on the expression of matrix metalloproteinases in gastrointestinal cancer and their inhibitors in treatment Page:—
5. Advancement of breast cancer and angiogenesis Page:—
6. Clinical and pathological analysis of primary malignant lymphoma of the breast Page:—
7. The value of ~(99m)Tc-MIBI imaging in differentiating of breast masses Page:—
8. Clinical analysis of radiotherapy plus drug intra-cavitary infusion for 184 patients on carcinoma of the bladder after operation Page:—
9. Clinical features and management of mucosa-associated lymphoid tissue lymphoma Page:—
10. Advances in research on relationship between mitochondrial genome and tumor Page:—
11. 3DRT for 35 patients with malignancy biliary obstruction Page:—
12. Blue sentinel lymph node detection in patients with cervical cancer Page:—
13. Evaluation of recurrent gastric malignancy with computed tomography Page:—
14. The diagnosis and treatment of rectal carcinoid: a report of 43 cases Page:—
15. Clinical study on thalidomide alone or combined with dexamethasone in the treatment of relapsed and refractory multiple myeloma Page:—
18. Advances in research on molecular biological markers for the differential diagnosis of thyroid neoplasms Page:—
19. Advances in research on ATM as a target for novel radiosensitizers Page:—
22. Oxaliplatin combined with vinorelbine in drug resistant non-small-cell lung cancer Page:—
25. Radioguided sentinel lymph node biopsy in breast cancer Page:—
30. Antitumor efficacy of naked DNA expressed murine IL-12 in a murine hepatocellular carcinoma model Page:—
33. Immunophenotype and expression of cytotoxic granule proteins of nasal NK/T cell lymphoma and its significance Page:—
45. Clinica study comparing HMVP and MVP regimens in the treatment of advanced non-small cell lung cancer Page:—
48. Immediate effects of three different regimens in advanced colorectal cancers Page:—
51. Clinical study of late-course hyperfractionated radiotherapy in the treatment of local advanced non-small cell lung cancer Page:—
52. Diagnosis and treatment of the accessory breast tumors Page:—
53. Phase I trial of weekly docetaxel(D) plus cisplatin(C) in the treatment of advanced non-small cell lung cancer(NSCLC) Page:—
54. The rectal administration of morphine sulphate controlled release tablets in the treatment of cancer pain Page:—
55. Effect of HELICOBACTER PYLORI infection on apoptosis and proliferation along with P53 gene expression in gastric epithelium Page:—
56. A study on expression of KGF mRNA in human NSCLC and its role in the development of lung cancer Page:—
57. Postoperative irradiation after radical surgery of esophageal carcinoma Page:—
58. Ifosfamide and other 3 drugs chemotherapy for 24 cases with recurrent intermediate—high grade non-Hodgkin's lymphoma Page:—
59. Expression of CD44V6 and p53 gene mutation in human ovarian carcinoma Page:—
60. Effect of insulin-like growth factor 1 receptor ?-strain interrupted on lung adenoma cell line SPC-A-1 Page:—
61. Therapeutic effect of rhG-CSF on grade Ⅳ leukopenia induced by chemotherapy of malignant tumor Page:—
62. Adervances in the research of multidrug resistance-associated protein's biological characters and mechanism Page:—
63. Advances of the research on the correlation of nitric oxide and the generation,development and metastasis of tumors Page:—
64. Advances of gemcitabin in non-small-cell lung cancer Page:—
65. Developments in the chemotherapy treatment for advanced colorectal cancer Page:—
66. Preservation of cervical plexus in the functional neck dissection of differentiated thyroid cancer Page:—
67. Vinorelbine plus oxaliplatin in the treatment of advanced non-small-cell lung cancer Page:—
68. Gemcitabine and carboplatin combination chemotherapy for 27 cases of advanced non-small-cell lung cancer Page:—
69. Surgical treatment of substernal benign thyroid tumor Page:—
70. Detection of serum vascular endothelial growth factor level before radiotherapy in cancer patients and its clinical significance Page:—
71. High-dose epirubicin combination therapy in the treatment of 48 cases with advanced chest malignant tumors Page:—
72. Paclitacxel and carboplatin in advanced non-small-cell lung cancer Page:—
73. Application of rhG-CSF in children's acute leukemia Page:—
74. Surgical treatment of esophageal and cardiac cancer in elderly patients Page:—
75. Quantitative study on PCNA, AgNOR, DNA content and nuclear morphometry of colorectal cancer Page:—
76. Vinorelbine plus cisplatin in the treatment of 48 cases with advanced non-small-cell lung cancer Page:—
77. Comparison of the therapeutic effect of several drugs infused into the bladder for superficial tumors after transurethral resection of the bladder tumor Page:—
78. Docetaxel administered as three consecutive weekly infusions plus cisplatin for advanced non-small-cell lung cancer Page:—
79. Antitumor effects of CIK cells against hepatocellular carcinoma cells in vitro and in vivo Page:—
80. Short-term efficacy of combination of MabThera and CEOP regimen in the treatment of aggressive B-cell lymphoma Page:—
81. CT and MRI evaluation of peripheral primitive neuroectodermal tumors Page:—
82. Feasibility of ~1H-MRS in the DEN induced rat hepatocellular carcinoma by a new 1.5T MR scanner Page:—
83. HER-2/neu gene amplification and expression in nasopharyngeal carcinoma and their clinical significance Page:—
84. Expression and clinical significance of tGF-?1,Cyclin E in gallbladder carcinoma Page:—
85. Analysis of indications for adjuvant treatment in node-negative breast cancer Page:—
86. Effect of 1,2:5,6-dianhydro-3,4-diacetylgalactitol and p53 gene transfection for the growth of hepatocellular carcinoma Page:—
87. Expression of p27~(Kip1) and cyclin D1 in human gastric carcinoma and its prognostic significance Page:—
88. Expressions of MDR and GST-? related to the response of neoadjuvant chemotherapy and prognosis in cervical cancer Page:—
89. Development of Chemotherapy in Colorectal Cancer Page:—
90. Expression of human vascular endothelial growth factor in ampullary carcinoma and its significance Page:—
91. Construction of antisense VEGF eukaryotic expression vector and effect to ovarian cancer cell Page:—
92. Intra-artery infusion chemotherapy plus radiation therapy for the treatment of invasive bladder cancer Page:—
93. A technical study of radiotherapy after surgery for gastric carcinoma Page:—
94. The incidence of axillary metastases and appropriate surgery for ductal carcinoma in situ of the breast Page:—
95. Relationship between involved extent of lymph node parenchyma and prognosis of patients with stageⅢ non-small-cell lung cancer Page:—
96. Relationship of chronic myelocytic leukemia and angiogenesis factors Page:—
97. Analysis of treatment and prognosis of vulvar cancer in 51 cases Page:—
98. Continuous low dose vinorelbin with cisplatin in the treatment of advanced non-small-cell lung cancer Page:—
99. Prognostic factors of patients with liver metastases from colorectal cancer Page:—
100. Treatment and prognosis of gastric cancer in the patients older than 70 years Page:—
101. Diagnosis and multidisciplinary treatment of 9 cases of pregnancy-associated breast cancer Page:—
102. Advances and prospects in head and neck tumor surgery Page:—
103. Advances in the research on correlation between homeobox genes and tumors Page:—
104. Research advances of National Surgical Adjuvant Breast and Bowel Project breast cancer trials Page:—
105. Adjuvant treatment of 126 cases of stage Ⅰb、Ⅱa cervical carcinoma after radical hysterectomy and pelvic lymphadenectomy Page:—
106. Targeted therapy in the management of colorectal cancer Page:—
107. The study of combined treatment for advanced endometrium carcinoma──A report of 45 cases Page:—
108. Pulmonary inflammatory pseudotumor:clinical characteristics and surgical treatment Page:—
109. Gemcitabine in the treatment of 8 cases with advanced liver cancer Page:—
110. Radiofrequency chemohyperthermia combined with intravenous chemotheray for malig nant ascites Page:—
111. Combination chemotherapy with navelbine(NVB) and epirubicin( e-ADM )in treating metastatic breast cancer Page:—
112. 36 cases of advanced NSCLC by combined chemotherapy based on gemcitabine Page:—
113. Neoadjuvant chemotherapy and preoperative radiation for stage Ⅰb-Ⅱb cervical cancer Page:—
114. Radiotherapeutic management of regional lymph nodes recurrence following mastectomy Page:—
115. Single-agent vinorelbine in the treatment of elderly patients with advanced non-small-cell lung cancer Page:—
116. Application of rhG-CSF in patients with plasma cell disease treated with autologus peripheral blood stem cell transplantation Page:—
117. Treatment of advanced pancreatic cance with gemcitabine,5-FU and cisplatine Page:—
118. Effect of amifostine on efficacy and hematologic toxicity in patients with advan ced non-small-cell lung cancer treated with chemotherapy Page:—
119. Metabolism and efficacy study of ~(125)I-anti-AFP administrated by interventional route for primary liver cancer Page:—
120. Tumor morkers in the diagnosis of malignant lung tumors Page:—
121. Biological response modifiers combined with radiotherapy and chemotherapy for stage Ⅲ non-small-cell lung cancer Page:—
122. Clinical benefit of gemcitabine plus cisplatin 3-week regimen for patients with advanced non-small-cell lung cancer (NSCLC): a prospective observational study Page:—
123. Clinical effect and side reactions of elderly patients with advanced NSCLC by gemcitabine with cisplatin Page:—
124. Influnce of doxoricin cytotoxicity by lipid peroxidation of docosahexaenic acids Page:—
125. Prognostic effect of cyclooxygenase-2 in non-small-cell lung cancer Page:—
126. Effects of p53 overexpression on the balance of helper T cell 1 with helper T cell 2 in colorectal tumors Page:—
127. Clinical significance and hematologic features of CD56~+ acute myeloid leukemia Page:—
128. Expression of VEGF and bFGF in xenografts of human osteosarcoma OS-732 on chick embryo chorioallantoic membrane and its significance Page:—
129. Initial study on gemcitabine with lipiodol emulsion in the treatment of advance dliver cancer Page:—
130. The construction of eukaryotic expressive vector of RI gene and the effects of the transfected pLNCX-ri on the growth of C6 glioma cells Page:—
131. Advances in research on relation of ubiquitin-proteasome pathway to malignancy Page:—
132. Surgical treatment and perioperative period management for 182 elderly patients with colonic carcinoma Page:—
133. Drainage and treatment of 12 cases with lung cancer hydropericardium by puncturing the pericardum and inserting central venous catheter into pericardial cavity Page:—
134. Clinical application of transdermal fentanyl for 30 patients with moderate or severe cancer pain Page:—
135. Continuous infusion of fluorouracil lasting 240 hours in 35 cases with gastric cancer Page:—
136. Effect of chemotherapy on plasma endothelin level in gastric carcinoma patients and its significance Page:—
137. Three different regimens of CF/5-FU,DDP in treatment of patients with advanced gastrointestinal adenocarcinoma Page:—
138. Expression and clinical studies on FLK-1,LRP and MDR1 in lung cancer patients Page:—
139. Carboplatin and cisplatin combined with etopside in patients with advanced non-small-cell lung cancer Page:—
140. Idarubicin combined chemotherapy regimen for 22 cases with refractory or relapsed multiple myeloma Page:—
141. Radiotherapy combined with the chemotherapy for 64 patients with advanced esophageal cancer Page:—
142. Signifance of serum CA153 in the differential diagnosis between benign and malignant lung diseases Page:—
143. Diagnostic utility of detection of CEA mRNA, CEA and CA19-9 in benign and malignant hydrothorax Page:—
144. Ki-67 antigen's expression in benign and malignant neoplasms of colorectum and its clinical significance Page:—
145. Therapy of murine gastric cancer by 5-FC/CD suicide gene system combined with HSP-PC tumor vaccine Page:—
146. Clinical value of video-mediastinoscopy in the diagnosis and treatment of intrathoracic diseases Page:—
147. Expression of Fas/FasL in lung cancer and its significance Page:—
148. Relation between apoptosis and proliferation or genes expression after chemotherapy in ovarian eithelial carcinoma Page:—
149. Effects of chemotherapy with gemcitabine in advanced non-small-cell lung cancer elderly patients Page:—
150. Expression and clinical significance of p27 in esophageal carcinoma Page:—
151. Correlation between the expression of gene protein of c-fos, bcl-2 and gastric cancer Page:—
152. Effects of stem cell factor in combination with erythropoietin on erythropoiesis in patients with anemia associated with non-Hodgkin's lymphoma Page:—
153. Expression of P53 and its relationship with HBV infection in hepatocellular carcinomas and chronic liver diseases Page:—
154. Effects of arsenic trioxide on different types of human ovarian cancer cell lines in vitro Page:—
155. Reversal effects of carvedilol on multidrug resistance in bladder cell lines Page:—
156. Curative effect of Serratia marcescens vaccine in treatment of malignant pleural effusion Page:—
157. Necessity of mediastinal lymph nodes dissection to cure patients with clinical-stage Ⅰ_A non-small cell lung carcinoma Page:—
158. Applications of three newer contrast-enhaced MRI sequences in the diagnosis of intracranial tumors Page:—
159. An initial study on serum CA125 in diagnosis to lung cancer Page:—
160. AZT inhibit telomerase activity of squamous cell carcinoma of tongue Page:—
161. Inhibition of survival pathway could sensitize the tumor cells to chemotherapy Page:—
162. Effect of NF?B family proteins on growth and drug-resistance of human ovarian cancer cell lines Page:—
163. Research on IGF-Ⅱprotein expression in lung cancer by tissue microarray Page:—
164. Advances in chemotherapy for upper gastrointestinal tumors Page:—
165. Autogenous peripheral stem cell transplantation combined with interleukin-2 for treatment of 16 patients with lymphoid malignancies Page:—
166. Feasibility of lung resection without blood transfusion for patients with lung cancer Page:—
167. Relationship between the occurence of acute respiratory failure after subototal esophagectomy and three-field lymphadenectomy and the choice of anesthesia and management Page:—
168. The relationship of platelet phospholipase A, and tumor Page:—
169. Postoperative radiation therapy in gastric cancer Page:—
170. Prognostic factors of early stage non-small cell lung cancer Page:—
171. Assessment on the efficacy of intraperitoneal chemotherapy on progressive gastric cancer after radical treatment Page:—
172. Clinical observation of oxaliplatin combination with 5-fluorouracil/folinic acid therapy in advanced colorectal cancer Page:—
173. Evaluation of jejunal interposition reconstruction P and SS type after total gastrectomy in patients with gastric carcinoma : reports of 31 cases Page:—
174. Paclitaxel combined with chemotherapy in the treatment of advanced breast cancer Page:—
175. Application of ultrasound guided mammotome minimally invasive biopsy system in 42 cases of breast mass Page:—
176. Clinical observation on the prevention of Doxorubicin-associated cardiotoxicity by astragalus injection Page:—
177. The clinical value of mammary sentinel lymphoscintigraphy in breast cancer Page:—
178. Preliminary study on the treatment of newly diagnosed multiple myeloma with thalidomide combined with chemotherapy Page:—
179. Effect of octreotide on transforming growth factor-alpha in human hepatocellular carcinoma cells Page:—
180. Clinical value of vascular endothelial growth factor in the diagnosis and treatment of common malignant tumors Page:—
181. The expression of uPA in gestational trophoblastic disease and the association with trophoblastic tumor invasiveness Page:—
182. Clinical analysis of the combined chemotherapy with navelbine concurrent with palliative radiotherapy on stage M, nasopharyngeal carcinoma Page:—
183. Preliminary study of intensity modulation radiation therapy for patients with prostate carcinoma Page:—
184. On the clinicopathology, ultrastructure and immunohistochemistry study of intracranial microcystic meningioma Page:—
185. Expression of CD117 in gastrointestinal stromal tumors and their significance Page:—
186. Pneumonectomy of right lung and carinal resection and reconstruction for lung cancer in 12 patients Page:—
187. Effect of thymosin ?1 for advanced non-small-cell lung cancer in chemotherapy patients Page:—
188. Experimented gene therapy for prostate cancer with HSV-TK/GCV system Page:—
189. Vascular endothelial growth factor expression in non-small cell lung cancer and their clinical relation Page:—
190. Radiotherapy of stage Ⅰ and Ⅱ non-small cell lung cancer Page:—
191. Loss of Fhit expression and significance in non - small cell lung cancer Page:—
192. Advance in reseach on the diagnosis for pancreatic carcinoma by spiral CT Page:—
193. Detection of chromosome 8 abnormalities in carcinoma of endometrium (endometrial carcinoma of uterus) by fluorescence in situ hybridization( FISH) Page:—
194. The relationship between the expression of ET, the content of DNA and prognosis in lung cancer Page:—
195. Clinicopathological characritics and prognosis of large intestinal mucoid adenocarcinoma Page:—
196. Preserving fertility treatment for 40 patients with ovarian malignant tumors Page:—
197. Microcystins in drinking water and cancer mortality in a city along Taihu Lake Page:—
198. Consistency and controversy of surgical treatment on locally advanced NSCLC Page:—
199. Glucocorticoid up-regulated T?R-Ⅱ in ovarian cancer HO-8910 cells Page:—
200. Bone scan characteric findings for hypertrophic pulmonary osteoarthropathy (HPO) in patients with pulmonary diseases Page:—
201. Treatment evaluation of hepatectomy and chemotherapy for primary liver cancer Page:—
202. The relationship between LPS-induced iNOS mRNA expression and macrophages cytotoxic function Page:—
203. Retrospective study of PEFC chemotherapy regimen on primary carcinoma of fallopian tube Page:—
204. Effects of artesunate on the proliferation and apoptosis of gastric carcinoma cells Page:—
205. Expression of CD_(44)V_5 and nm23-H_1 gene in esophageal cancer Page:—
206. Combined chemotherapy with gemicitabine and cisplatin as preoperative induction treatment in patients of stage m a( N_2) NSCLC Page:—
207. Expression of midkine protein in non-small-cell lung cancer and its clinical significance Page:—
208. Anti-invasion and anti-metastasis effects of ginsenoside Rg3 on the hepatocellUlar carcinoma cell line Page:—
209. Chemokine and breast cancer metastasis Page:—
210. Analysis of causes and management of bronchus-pleural fistula after pneumonectomy of lung cancer Page:—
211. 3-D conformal radiotherapy for malignant thoracic tumors Page:—
212. Randomized study of low molecular weight heparin (LMWH) plus chemtherapy in advanced non-small cell lung cancer Page:—
213. The significance of TGF-?_1 in sera of patients with bladder cancer Page:—
214. Prevention and treatment of acute renal injury in tumor patients treated with body gama kinfe Page:—
215. Evaluation on the antiemetic effect of azasetron hydrochloride in patients with liver neoplasm after transcatheter arterial chemoembolization Page:—
216. Evaluation of urinary NMP_(22) in the detection of transitional cell carcinoma of bladder Page:—
217. Myelodysplastic syndrome transformed to atypical chronic myeloid leukemia——Three cases report and review of literature Page:—
218. Erythropoietin therapy for anemic patients with non-small cell lung cancer in combination chemotherapy Page:—
219. The influence of aspirin on apoptosis and Fas/FasL expression of Caco-2 cell Page:—
220. Comparison of conventional and conformal radiotherapy and different irradiation technique by 3D-TPS for esophageal carcinoma : a dosimetric study Page:—
221. Application of compartment resection in patients with extremity soft tissue sarcomas Page:—
222. Relationship between the effect of docetaxel inducing apoptosis of non - small - cell lung cancer cell and the intracellular level of reactive oxygen Page:—
223. Clinical significance of fatty acid synthase in non-small cell lung cancer Page:—
224. Differential diagnostic usefulness of CK19, S-100 protein and EMA in papillary carcinoma and papillary hyperplasia Page:—
225. Papillary carcinoma in a thyroglossal duct remnant Page:—
226. Expression of vascular endothelial growth factors VEGF, VEGF-C and flt-4 in breast cancer and its clinical pathological analysis Page:—
227. The effect of persortality on the mental adjustment of breast cancer patients during operation Page:—
228. Utility of computer -aided detection in the diagnosis of breast carcinoma with mammography Page:—
229. Breast cancer in older women Page:—
230. Current studies and evaluations of sentinel lymph node biopsy for breast cancer Page:—
231. Identifying factors related to bone metastasis in breast cancer Page:—
232. Review and evaluation for the key clinical trials that may change clinical practice of breast cancer Page:—
233. Character of drug targeting lymph nodes after regional injection of carboplatin-activated carbon in patients with breast cancer Page:—
234. The combination of navelbine and epirubicin as neoadjuvant chemotherapy in the treatment of locally advanced breast cancer Page:—
235. Influence of estrogen on the proliferation of MCF7, a human breast carcinoma cell line Page:—
236. Prognostic and predictive factors in lymph node negative breast cancer and establishment of mathematical model Page:—
237. Detection of CK-19 mRNA in peripheral blood from breast cancer patients by reverse transcription polymerase chain reaction Page:—
238. Clinical significance of the circulating chemokines in breast carcinoma patients Page:—
239. Multidisciplinary treatment of epithelial ovarian carcinoma in stage Ⅲ and prognostic analysis Page:—
240. Current status and advances in adjuvant therapy of operable breast cancer Page:—
241. Clinical significance of combined measuring CYFRA21-1,CA153 and NSE for lung cancer Page:—
242. Intraperitoneal chemotherapy combined with intravenous chemotherapy after operation in the ovarian epithelial cancer Page:—
243. New advances of taxol in clinical application of breast cancer Page:—
244. Research advances in drug transporters and multidrug resistance Page:—
245. Gemcitabine plus cisplatin for the treatment of anthracycine-resistant advanced breast cancer Page:—
246. Values of resecting the lymph nodes adjacent to the recurrent laryngeal nerve in the operation on cNo thyroid papillary carcinoma Page:—
247. Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy and prognosis Page:—
248. Three-dimensional conformal radiotherapy for brain gliomas Page:—
249. Phase Ⅱ clinical trial on docetaxel in the treatment of non-small-cell lung cancer Page:—
250. DNA polymerase ? gene mutation in gastric carcinoma and the relationship with H.pylori infection Page:—
251. Prognostic factors in 83 patients with cervical carcinoma treated with high-dose-rate brachytherapy and external radiotherapy Page:—
252. Chemotherapy adjunctive to definitive radiotherapy in locally advanced nasopharyngeal carcinoma (NPC):prospective randomized study Page:—
253. Apoptosis of lung adenocarcinoma SPC-A1 cells induced by Livin isoform-specific gene silencing Page:—
254. Three-dimensional conformal radiotherapy (3DCRT) in treating patients with recurrent nasopharyngeal carcinoma:planning optimization and dosimetry analysis Page:—
255. Microtubule-destabilizing protein stathmin—a new target for gene therapy of cancer Page:—
256. Diagnosis and therapy of 26 cases with primary malignant cervical lymphoma Page:—
257. Primary nasal type extranodal NK/T cell lymphoma of adrenal gland:clinical and pathological characters and immunophenotype Page:—
258. Clinical study of navelbine plus paclitaxel for patients with advanced breast cancer Page:—
259. The prognosis of patients with stage Ⅰb-Ⅱb node-negative cervical carcinoma Page:—
260. The clinical benefit of CPT-11 combined with 5-FU/CF for patients with locally advanced or metastatic colorectal cancer Page:—
261. Effect of IFN-? on the growth of human cervical cancer transplanted subcutaneously in nude mice Page:—
262. Animal study on the feasibility of regional gastroduodenal artery or splenic artery ligation followed by regional intraarterial perfusion of pancreas with 5-FU Page:—
263. Differential metastasis-related gene analysis of prostate cancer cells isolated from primary tumor and spontaneous metastases in nude mice with orthotopic injection of PC-3M cells by cDNA microarray Page:—
264. Effect of retroviral vectors carried sense or antisense TGF?1 on human bladder cancer cells in vitro Page:—
265. The study of lung adenocarcinoma serum biomarkers selected by surface-enhanced laser desorption ionization spectrometry Page:—
266. Reversal effect on ADM resistance in human leukaemia cell subline resistant to ADM(K562/ADM) of anti-FasL Page:—
267. Expression of cyclooxygenase-2,vascular endothelial growth factor and their prognostic significance in gastric carcinoma Page:—
268. Influence of wild-type p53 gene tranfection on telomerase activity in human HCC-9204 cell Page:—
269. Expression of MEK-1 in regulation of ?V integrin and E-cadherin of MCF-7 breast cancer cells Page:—
270. 18?-glycyrrhetinic acid-induced apoptosis and changed intracellular Ca~(2+) concentration in human breast carcinoma cells Page:—
271. Preliminary application of the sentinel lymph node detection in early cervical cancer Page:—
272. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in cervical carcinomas and its significance Page:—
273. Expression of metastasis suppressor gene Kai1 in ovarian epithelial tumor and its significance Page:—
274. Survivin ,P21~(WAF1/CIP1),Cyclin D1 proteins expression in cervical carcinoma:correlations with recurrence of early stage cervical cancer of the uterus Page:—
275. The clinical analysis of chest wall recurrence of breast cancer after mastectomy Page:—
276. Advances in dendritic cells vaccines Page:—
277. The connective tissue growth factor and angiogenesis in breast carcinoma Page:—
278. Morphine controlled-release tablets plus diclofenac sodium in the treatment of pain of bone metastatic carcinoma Page:—
279. Value of radiotherapy following breast-conserving surgery in early stage breast cancer Page:—
280. Study on antisense oligodeoxynucleotide targeting survivin inducing apoptosis of K562/A02 cells Page:—
281. Analysis of chromosome variation of lymphocytes and comparative genomic hybridization of lung carcinoma in patients with long survival after operation Page:—
282. Surgery combined with intraoperative radiotherapy compared with surgery alone for rectal carcinoma Page:—
283. Evaluation of ~(18)F-FDG hPET/CT in primary carcinoma of gastric cardia Page:—
284. Phase Ⅱ clinical study of gemcitablineplus etoposite in treatment of advanced non-small-cell carcinoma Page:—
285. Clinical study of chemoradiation therapy in rectal cancer Page:—
286. Expression of survivin in gastric carcinoma and analysis of its correlation with COX-2 Page:—
287. Phase Ⅱ clinical study of intratumoral H101,an E1B deleted adenovirus,in patients with cancer Page:—
288. BSO up-regulating cisplatin sensitivity of a MRP-overexpression lung cell line SPC-A-1 by changing the activity of GSH detoxification system Page:—
289. The inhibition of the malignant phenotype of human hepatic carcinoma cell line by antisense ?-catenin cDNA Page:—
290. Advances in the adjuvant radiotherapy on hilar cholangiocarcinoma Page:—
291. The value of three-field lymphadenectomy for carcinoma of the esophagus Page:—
292. Vinorelbine combined with cisplatin in advanced stage non-small-cell lung cancer Page:—
293. Combination chemotherapy with paclitaxel and oxaliplatin in 30 patients with advanced gastric cancer Page:—
294. Neoadjuvant chemotherapy with epirubicin plus paclitaxel in treatment of patients with breast cancer Page:—
295. Prognostic factors of medullary thyroid carcinoma: clinical analysis of 73 cases Page:—
296. The change of serum erythropoietin level in patients with cancer anemia Page:—
297. Autocrinism of vascular endothelial growth factor in human hepatocellular carcinoma cell and its significance Page:—
298. Inhibitory effect of STI571 in combination with chemotheraputic drug on a multi-drug resistant leukemia cell line expressing bcr-abl Page:—
299. Radiotherapy in the patients with bladder carcinoma treated by conservative surgery Page:—
300. Transcatheter arterial chemoembolization combined with 3-dimensional conformal radiotherapy for primary hepatic carcinoma Page:—
301. Expression of KAI1 protein and its clinicopathological significance in breast cancer Page:—
302. Expression of matrix metalloproteinase-2 in lymph node-negative breast carcinoma and its clinical value Page:—
303. Clinical application criteria and progress in ?(X) stereotatic radiotherapy Page:—
304. Advances in clinical application of CT in the image-guided radiotherapy Page:—
305. Clinical and pathological features of desmoplastic small round cell tumor Page:—
306. Progress in the treatment of loco-regionally advanced nasopharyngeal carcinoma Page:—
307. Treatment progression of early nasopharyngeal carcinoma Page:—
308. Current status of radiotherapy for non-Hodgkin's lymphoma Page:—
309. Relationship between postive MMP-9, Cath-D and biological behaviors in gastric carcinoma Page:—
310. Concurrent chemoradiotherapy in cancer treatment Page:—
311. Advances in research of MAGE-A3 Page:—
312. Expression of cyclooxygenase-2 and its clinicopathologic and prognostic significance in endometrial cancer Page:—
313. Relationship between hypoxia and estrogen receptor alpha in human breast cancer Page:—
314. The prognostic significance of breast cancer resistance protein (BCRP) expression in primary breast carcinoma Page:—
315. Detection of bone marrow involvement using flow cytometry in B cell lymphoma Page:—
316. Expression of matrix metalloproteinase-9 and its correlation with tumor interstitial microvascular density and tumor metastasis in transitional cell carcinoma of the bladder Page:—
317. Expression of Survivin gene in human non-small-cell lung cancer: association with Caspase-3 and Bcl-2 Page:—
318. The study on the expression of HIF-1? and its association with the expression of HER-2 and survivin in breast carcinoma Page:—
319. Study of CK19 mRNA in blood of patients with colorectal cancer Page:—
320. Expression of Bcl-2, integrin ?3 protein in resected non-small cell lung cancer and its clinical relevance Page:—
321. Research advances in breast cancer resistance protein (BCRP) Page:—
322. Treatment of 34 cases of non small cell lung cancer in the elderly patients using vinorelbine and oxaliplatin Page:—
323. Advanced cholangiocarcinoma treated with gemcitabine combined with 5-FU: An initial study of short-term therapeutic effect Page:—
324. Irinotecan plus 5-FU/LV in line 2 treatment for metastatic colorectal cancer Page:—
325. Docetaxel as second-line treatment in 23 patients with advanced non-small cell lung cancer Page:—
326. Postoperative radiotherapy in patient with early stage uterine sacomas Page:—
327. The impact of cell period and cell surface antigen in cervical cancer cell lines by interferon-? gene transfer Page:—
328. Application of video-assisted thoracospic surgery for lung cancer as viewed via lymphadenectomy Page:—
329. New advances of pemetrexed (Alimta~) in the treatment of non-small-cell lung cancer Page:—
330. Extended operation for non-small lung cancer invading left atrium and great vessels and trachea carina Page:—
331. Influence of some factors on the prognosis of the postoperative stage ⅢA-N2 non-small cell lung cancer Page:—
332. Influence of doxorubicin chemotherapy on the expression of epithelial growth factor in the Balb/c mouse hepatocarcinoma Page:—
333. Expression and clinical significance of PTEN in non-small cell lung cancer Page:—
334. Clinicopathological analysis of solid-pseudopapillary tumor of the pancreas Page:—
335. Study on the expression of cyclooxygenase-2 protein in gastric carcinoma and correlation with P-glycoprotein Page:—
336. Establishment of a human large cell lung cancer multi-drug resistance cell line H460/cDDP and its biological characteristics Page:—
337. The induction of apoptosis by epigallocatechin-3-gallate in xenograft nude mice with human gastric cancer cells Page:—
338. Detection of Epstein-Barr Virus(EBV) and expression of EBV lytic genes in EBV-positive gastric carcinomas Page:—
339. Advances in radiation therapy for early stage breast cancer Page:—
340. The genetic polymorphisms of N-acetyltransferase 1 and the genetic susceptibility to primary liver cancer in Luoyang, China Page:—
341. Regulation of tumor suppressor gene methylation in human gastric cancer Page:—
342. Progress of selecting tumor markers using SELDI ProteinChip technique Page:—
343. Research advances in uterine papillary serous carcinoma Page:—
344. Venorelbine combined with fluorouracil/leucovorin in patients with nasopharyngeal carcinoma refractory to platinum based chemotherapy Page:—
345. Analysis of the reasons for postoperative complications and death of thoracic tumors Page:—
346. Synergistic anti-cancer effects and mechanisms of huachansu plus vinorelbine on Lewis lung cancer cell in mice Page:—
347. Expression of survivin,caspase-3 in gastric carcinoma by using tissue microarray and its significance Page:—
348. Regulative effect of arsenic trioxide on the drug-resistant protein in MR_2 cell lines Page:—
349. Vinorelbine combined with capecitabine in the treatment of advanced and metastatic breast cancer Page:—
350. Surgical treatment for esophageal cancer:current status and future directions Page:—
351. Development of advanced gastric cancer treated with weekly administration of paclitaxel Page:—
352. Treatment of liver metastasis of colorectal cancer Page:—
353. Advances in chemotherapy and radiofrequency ablation of colorectal cancer liver metastases Page:—
354. Clinical diagnosis,treatment and prognosis stuty of 22 cases of meningeal metastasis Page:—
355. Recent advances of surgical treatment for rectal cancer Page:—
356. Three platinum-based regimens to treat patients with advanced NSCLC:a clinical investigation Page:—
357. Treatment of advanced and metastatic colorectal cancer with combined chemotherapy based on oxaliplatin,irinotecan and fluorouracil Page:—
358. Effect of doses of three-dimensional conformal radiotherapy for unresectable biliary cancer Page:—
359. Clinical features and therapy of the elderly hepatic portal cholangiocarcinoma Page:—
360. Detection of cytokeratin 19 (CK19) mRNA and human papillomavirus type 16 (HPV16) mRNA in peripheral blood of cervical cancer patients and its significance Page:—
361. Investigations of synchronization of expression between apoptosis and P27~(Kip1),PCNA in esophagus squamous cell carcinoma Page:—
362. Advances in surgery of rectal cancer Page:—
363. Target for tumor hypoxia Page:—
364. Analyses of clinical results of treatment with gemcitabine and cisplatin for advanced hormone independent prostate cancer Page:—
365. The impact of hypoxia-inducible transcription factor-1? on ovarian carcinoma cell Page:—
366. The evaluation of the implementation of “Guidelines of Diagnosis and Treatment for Common Cancers in China (Breast cancer)” in Shanghai Page:—
367. Clinicopathological factors associated with recurrence in malignant ovarian germ cell tumor: a report of 145 cases Page:—
368. Homozygous deletion of p15、p16 genes and its co-deletion of p15/16 genes in serum DNA of the epithelial ovarian cancer Page:—
369. Construction of recombinant adenovirus with Egr-1 promoter and Smad7 Page:—
370. Pancreaticoduodenectomy for the surgical treatment of advanced gastric carcinoma Page:—
371. The chemotherapy of oxaliplatin combined with capecitabine in advanced gastric cancers Page:—
372. Fluorouracil/leucovorin combined with oxaliplatin or paclitaxel in patients with advanced gastric cancer Page:—
373. Advanced understanding in the effect of hypoxia on the expression of matrix metalloproteinase in the promotion of tumor-metastasis Page:—
374. The significance of proteomics in the discovery of hepatocellular carcinoma biomarker Page:—
375. NSAIDs induced apoptosis of gastric cancer cell lines and the mechanism Page:—
376. Neoadjuvant chemotherapy followed by radical surgery for the treatment of locally bulky cervical carcinoma Page:—
377. The application of direct machine parameter optimization technique in the treatment of nasopharyngeal carcinoma Page:—
378. Clinical significance of p53 expression in colorectal cancer patients Page:—
379. DC loaded with CPP-Id increase the efficiency of CTL proliferation and enhance its cytotoxicity in vitro Page:—
380. Study on histopathology of the mouse forestomach neoplasm inducd by B(a)P Page:—
381. Clinicopathological features and management of gastrointestinal borderline lesion and correlative lesion Page:—
382. Advances in research of CD30~+ anaplastic large cell lymphoma Page:—
383. Progress of the relationship between cyclooxygenase-2 and breast cancer Page:—
384. Advances in diagnosis and management of malignant pleural mesothelioma Page:—
385. Capecitabine in the treatment of relapsed breast cancer Page:—
386. Relationship of chemosensitivity on cancer in vitro and the clinical experience Page:—
387. Salvage treatment of primary recurrence in patients with laryngeal cancer after definitive radiotherapy Page:—
388. Preliminary results of radiotherapy plus ultrasound hyperthermia for malignant tumors Page:—
389. Efficacy of capecitabine combined with intrahepatic transcatheter arterial chemo embolization in primary hepatic carcinoma Page:—
390. Gemcitabine plus cisplatin vs gemcitabine plus carboplatin in patients with adva nced non-small-cell lung cancer Page:—
391. Three-dimensional conformal radiotherapy(3-DCRT)combined with radiofrequency hyperthermia for locally advanced non-small-cell lung cancer(LANSCLC) Page:—
392. Combinations of neoadjuvant chemoradiotherapy and transurethral resection for bladder cancer with muscle invasion Page:—
393. Analysis of dose-volume dependence of acute esophagitis using a random-effect model for concurrent chemoradiation therapy for non-small-cell lung cancer (NS CLC) Page:—
394. Gemcitabine and carboplatin used as induction regimen for elderly patients with locally advanced unresectable non-small cell lung cancer Page:—
395. Expression and clinical significance of MDR_1 / P-gp,C-erbB-2 in breast cancer Page:—
396. Immortalization of cultures derived from primary breast carcinoma by ectopic expression of human telomerase reverse transcriptase and its significance Page:—
397. Role of Bcl-2 Phosphorylation in mediating paclitaxel induced-apoptosis in hum an retinoblastoma Y79 cells Page:—
398. Gene diagnosis and clinical significance of micrometastases in lymph nodes, peri pheral blood and bone marrow in non-small-cell lung cancer patients Page:—
399. Advances research in third generation aromatase inhibitors in adjuvant therapy of postmenopausal women with early breast cancer Page:—
400. CGH and advances in the study of colorectal carcinoma Page:—
401. The clinical efficacy observation of VAD regimen in the treatment of newly diagn osed multiple myeloma Page:—
402. Analysis of clinical characteristics of premenopausal and postmenopausal female patients with breast cancer Page:—
403. Comparison between old and new clinical staging of primany liver cancer Page:—
404. Study of approaches in surgery of esophageal cancer Page:—
405. Docetaxel plus prednisone versus mitoxantrone plus prednisone for metastatic hormone-refractory prostate cancer in chinese patients:experience of a single center Page:—
406. Progress in the treatment of hormone prostate cancer Page:—
407. Gemcitabine and cisplatin combination chemotherapy in refractory metastatic breast cancer Page:—
408. Hormonal therapy for metastatic prostate cancer Page:—
409. Study of mechanism of radiation sensitizing effect of topotecan on nasopharyngeal carcinoma Page:—
410. Three dimensional conformal radiotherapy for metastasis of retroperitoneal lymph node Page:—
411. The relationship between postoperative survival rate and clinical stage of gallb ladder carcinoma Page:—
412. Coxmultivariate regression analysis of prognostic factors for extrahepatic chol angiocarcinoma Page:—
413. Histologic detection of non-sentinel lymph node of early breast cancer patients with positive sentinel lymph node and its clinical significance Page:—
414. Diagnosis and treatment of Hashimoto’s disease complicated with thyroid cancer Page:—
415. Comparison of the two methods for screening osteosarcoma cell sublines with different metastatic potential in vitro Page:—
416. Advances in the research on Tiam 1 and tumor invasion and metastasis Page:—
417. Advances in research of tumor infiltrating dentritic cells Page:—
418. Operative approach in patients with carcinoma of the middle third of esophagus determined by preoperative CT scan Page:—
419. RNA interference mediated inhibition of epidermal growth factor receptor expression and its significance in different human cancer cell lines Page:—
420. Gemcitabine single-agent in the treatment of elderly advanced cancer Page:—
421. Gemcitabine plus cisplatin in treatment of recurrent ovarian cancer Page:—
422. Expression of fatty acid synthase in bladder transitional cell carcinoma and its significance Page:—
423. Three-weeks’ and weekly taxotere/cisplation treatment in non-small-cell lung cancer Page:—
424. Comparison of CT and MRI in detecting skull base invasion in nasopharyngeal carcinoma Page:—
425. (18)~F-deoxyglucose-hPET in the detection of recurrence in non-small-cell lung cancer Page:—
426. Clinical character and therapy of acquired fungemia in acute leukemia patients Page:—
427. Effect of sodium selenate on the viability and proliferation of PC-3 cell line, a kind of human prostate cancer cell Page:—
428. Relationship between the expression of cyclin B1 gene and drug resistance in patients with acute leukemia Page:—
429. Phase Ⅱ study of recombinant human interleukin-11 treatment for chemotherapy-induced thrombocytopenia Page:—
430. Peripheral blood stem cell transplantation for the treatment of 11 cases with acute leukemia and malignant solid tumors Page:—
431. Relationship between blocking of N-acetylglucosaminyltransferase V in hepatocarcinoma cells and cellular endoplasmic reticulum stress Page:—
432. Influence of MRI on the staging system of 78 patients with nasopharyngeal carcinoma (NPC) Page:—
433. Expression of the estrogen receptor and Cyclin D1 in differentiated thyrord carcinoma and its clinical significance Page:—
434. Primary renal lymphoma of mucosa-associated lymphoid tissue: report of 2 cases and review of literatures Page:—
435. Reversal of multidrug resistance by neferine in human gastric carcinoma cell line SGC7901/VCR Page:—
436. Expression of MT1-MMP, EMMPRIN, P-gp in gastric carcinoma and their correlation Page:—
437. Expression of heat shock protein 27 mRNA in the carcinogenesis of esophageal squamous epithelium Page:—
438. Inhibitory effect on human breast cancer SKBr-3 cells by RNA interference of survivin gene Page:—
439. Advance in the study of CD4~+CD25~+FOXP3~+ regulatory T cell in tumor immune evasion Page:—
440. Gemcitabin plus capecitabine as a second-line chemotherapy for patients with advanced breast cancer Page:—
441. Expression of CXCR4 in lung cancer and its significance Page:—
442. Surgery for stage Ⅳ non-small cell lung cancer Page:—
443. Endocrine system disturb induced by antineoplastic agents Page:—
444. The position and progress of rediotherapy in NSCLC Page:—
445. Minimally invasive treatment of lung cancer Page:—
446. Lymphomas with CARMA1, BCL10, MALT1 and NF-?B signaling pathway Page:—
447. Research on the correlation of Disabled-2 gene and tumors Page:—
448. Analysis and discussion of clinical pathology of 864 cases with breast diseases Page:—
449. Studies on a selective cyclooxygenase-2 inhibitor celecoxib inhibiting growth of human hepatocellular cancer SMMC-7721 cells lines and inducing apoptosis Page:—
450. Research progress of the relationship between HGF/Met and invasion of thyroid carcinoma Page:—
451. Effect of 2-methoxyestradiol on apoptosis of bone marrow cells of patients with multiple myeloma Page:—
452. Expression and significance of PAI-1 in nasopharyngeal carcinoma (NPC) cell line(CNE-2Z) and its sub-line (CNE-2Z-H5,CNE-2Z-H5-9) Page:—
453. Induction of apoptosis by TNF-related apoptosis-inducing ligand in human ovarian cancer cells Page:—
454. Renal cell tumor and renal cyst(Report 64 cases) Page:—
455. The clinical characteristics of different pathological subtypes of cyst-associated renal cell carcinoma Page:—
456. A study on expression changes of a tumor suppressor WWOX in human lung adenocarcinoma cell line A549 Page:—
457. A randomized study of peri-operative chemotherapy in patients with completed resected non-small-cell lung cancer Page:—
458. The inhibitory effect of DLX4 RNAi on adhesion and invasion ability of choriocarcinoma cells Page:—
459. Relationship of the prognosis of lung cancer with brain metastases and the expressions of p53,nm23 and VEGF Page:—
460. Rho family expression in neoplasms and its clinical significance Page:—
461. Detection of CK19 mRNA and CK20 mRNA in peripheral blood cells of patients with early cervicalcancer and its clinical significance Page:—
462. Three-dimensional conformal radiation therapy plus arterial iufusion chemotherapy for pancreatic cancer Page:—
463. Percutaneous portal vein chemoembolization in the treatment of primary hepatic carcinoma with portal veintumor thrombus Page:—
464. Therapeutic effects of 3-dimensional conformal radiotherapy(3D-CRT) and concurrent chemotherapy in advanced non-small-cell lung cancer(NSCLC) Page:—
465. Surgical treatment of 15 tracheoesophageal fistulas secondary to carcinoma of esophagus after radiotherapy Page:—
466. Prognostic factors of 152 cases with Ⅲ/Ⅳ stage nasopharyngeal carcinoma Page:—
467. Effect of gemcitabine plus cisplatin in advanced breast cancer with anthracycines and /or taxanes resistance Page:—
468. Role of telomere, telomerase and hTERT in colorectal carcinoma Page:—
469. Measurement of serum and urine TGF?1 level in bladder cancer patients and its clinical significance Page:—
470. Relationship between the expression levels of cell cycle regulators and the proliferation ability of human giant-cell lung carcinoma cell strains 95C and 95D Page:—
471. Relationship between polymorphisms of DNA repair gene XRCC1 and susceptibility to lung cancer Page:—
472. Aberrant expression of B7-H4 and BTLA in tumormodel Page:—
473. CEA DNA vaccine induces special cellular and humoral immune response to a carcinoembryonic antigen in mice Page:—
474. Interactions between the epidermal growth factor receptor and typeⅠ protein kinase A in therapy of malignant tumor Page:—
475. Progression on response and prognosis of lung cancer and single nucleotide polymorphism Page:—
476. Expression of MMP-11 in serum of gastric cancer and its significance Page:—
477. Evaluation of intraoperative touch imprint cytology diagnosis of sentinel lymph nodes in breast cancer Page:—
478. Influence of MRI on the Chinese 1992 staging system of nasopharyngeal carcinoma (NPC) Page:—
479. Immunophenotype character of malignant lymphoma with bone marrow involvement Page:—
480. Study on changes of bcl-2 expression in apoptosis of PGCl_3 cells induced by DAPK Page:—
481. Clinicopathologic features and DNA ploidy of sporadic colorectal cancers with microsatellite instability Page:—
482. The effect of shRNA-CXCR4 on breast cancer cell growth and proliferation in vitro Page:—
483. Inhibitory effects of chemically synthetic siRNA on the expression of E6 gene in the cervical cancer cell line SiHa Page:—
484. Study on the expression level of esophageal carcinoma P-gp and P27 and affecting survival in the patient Page:—
485. Impact of Qingyi Xiaoji Decoction on gene expression of experimental pancreatic cancer in vivo Page:—
486. Detection of BRCA1 gene promoter hypermethylation in plasma of sporadic breast cancer patients Page:—
487. Multivariate analyses of prognostic factors for breast cancer patients with liver involvement Page:—
488. Effect of CD40 ligandization on breast cancer cell line and endothelial vein cell lline in vitro Page:—
489. PTEN inhibited the invasion of glioma cells with a common mutant epidermal growth factor receptor expression by dephosphorylating FAK Page:—
490. A study on regulation of DNA mismatch repair genes MLH1 and MSH2 in human SCLC cell line H446 under hypoxic condition Page:—
491. The research of different MRI-CT image registration for the stability of radiotherapeutic target delineation on gliomas after surgery Page:—
492. Relationship of oncogene survivin、c-erbB-2 expression in breast cancer and its prognostic significance Page:—
493. Cloning of 5'flank upstream regulation region of LCRG1 and the measurement of promoter activity Page:—
494. Effects of EGCG on regulating NF-?B/p65 induced by TNF-? and on inducing apoptosis Page:—
495. Effects of MAPK on a human inflammatory breast carcinoma cell line Page:—
496. Breast-conserving therapy of early stage breast cancer Page:—
497. Research progress on the mechanism of invasion and metastasis of colorectal carcinoma Page:—
498. Problems of target defined in nasopharyngeal carcinoma Page:—
499. Advances in research on CLN3 gene and diseases Page:—
500. Advances in research on the diagnosis and therapy of lung cancer with bone metastases Page:—
501. Analysis of mortality trends of digestive system cancer in Henan Province from 1987 to 2006 Page:—
502. Expression and significance of Glut1 and HIF-1? in human hepatocellular carcinoma Page:—
503. Single agent vinorelbine for the treatment of advanced non-small-cell lung cancer in 27 elderly patients Page:—
504. Comparison between urinary cytokeratin test and voided urine cytology for detection of bladder cancer Page:—
505. p16 gene methylation status of and its effect on mRNA expression in hepatocellular carcinoma Page:—
506. Influence of dose distribution selected from different beam orientation for a nasopharyngeal carcinoma IMRT plan Page:—
507. Sequential chemotherapy and conventional radiotherapy in treatment of 45 cases of brain metastases of lung cancer Page:—
508. The anti-tumour effect of Wuxing soup and its effect on the immunity of melanoma mice Page:—
509. Otolaryngeal mucoepidermoid carcinoma:a clinicopathological study of 15 cases Page:—
510. Canstatin high level expression system and its biology effects on lung cancer Page:—
511. Correlation between Akt phosphorylation and loss of PTEN protein expression in non-small-cell lung cancer Page:—
512. The clinicopathologic characters and prognosis of cervical cancer in 831 young women under 35 years old Page:—
513. Expression of vWF and integrin?_3 in H460 cells and association between the two factors and tumor metastasis Page:—
514. Effect of hydroxycamptothecin with thermotherapy on angiogenesis in vivo and in vitro Page:—
515. Gene expression of tyrosine kinase receptor pathway in primary glioblastoma and its significance Page:—
516. Expression of CD4~+CD25~+ regulatory T cells in colorectal cancer patients and its significance Page:—
517. Inhibitory effects of shRNA targeting CD44v3 on invasion behavior of human colon cancer cell SW480 in vitro induced by hyaluronan Page:—
518. Clinical biology value of p53 overexpression in Chinese breast cancer by Meta analysis Page:—
519. Colorectal cancer screening Page:—
520. Targeted therapies in the treatment of gastric cancer Page:—
521. A clinical control study on transcatheter arterial infusion chemotherapy in combination with hyperthermia for mid and advanced non-small cell lung cancer Page:—
522. Application of proteomic techniques in searching lung cancer biomarkers Page:—
523. Do the patients with esophageal cancer benefit from higher radiation dose?——Dose escalation of 3-D conformal radiation therapy in the patients with esophageal cancer Page:—
524. The expression of breast cancer resistance protein(BCRP) in primary breast carcinoma and its clinical impact Page:—
525. Study of cell growth inhibition and apoptosis induced by oxaliplatin in human poor differentiation nasopharyngeal carcinoma cell line-CNE2 Page:—
526. Combined treatment for locally advanced esophageal cancer Page:—
527. Investigation of standardized treatment in the locally advanced esophageal carcinoma Page:—
528. The value of imaging tools in staging esophageal carcinoma before therapy Page:—
529. Advances on immunohistochemistry and genetical detection in diagnosis of synovial sarcoma Page:—
530. Study on expression and clinical significance of uPAR and VEGF-C in ovarian cancer Page:—
531. Advances in the study of carotid injury after radiotherapy in head and neck tumors Page:—
532. Clinical characteristics,treatment and prognosis of 11 cases with extraovarian peritoneal serous papillary carcinoma Page:—
533. The effect of HPA gene transfection on the proliferation、adhesion、invasion of human ovarian cancer cell line SKOV3 Page:—
534. Advances in research on clinical use of electronic portal imaging device(EPID) Page:—
535. Endocrine glands-derived-vascular endothelial growth factor and tumor Page:—
536. Research advances in detection and clinical significance of circulating HPV DNA in patients with cervical cancer Page:—
537. Theraputical effect of Mammotome vacuum biopsy system on breast benign masses Page:—
538. Preliminary isolation and identifi cation of cancer stem-like cells in colon cancer cell line SW480 Page:—
539. Effects of hypoxia on apoptosis of human lung adenocarcinoma A549 cell line by adriamycin Page:—
540. Role of EGFR-STAT3 signal pathway in carcinogenesis of experimental hepatoma in rats Page:—
541. Application of ATP-tumor chemosensitivity assay in primary epithelial ovarian cancer(PEOC) Page:—
542. Reconstruction following total gastrectomy Page:—
543. The cancer genome anatomy project: building a bioinformatics index in cancer research fields Page:—
544. The study of ~(99m)T_C-sulphur colloidal particles’ properties and internal mammary sentinel nodes lymphoscintigraphy Page:—
545. Screening on the tumor related markers in the serum of the renal cell carcinoma patients by the SELDI-TOF-MS technique Page:—
546. Structure and function of Mac-1 and its role in cancer immunotherapy Page:—
547. c-kit and PDGFRA gene mutation in gastrointestinal stromal tumors and its significance Page:—
548. Effect on proliferation of SW480 cell line with p33~(ING1b) genetransfection Page:—
549. VM_(26)+DDP regimen given concurrently with whole-brain radiotherapy for brain metastasis from lung cancinoma Page:—
550. The significance of HPV-DNA testing in diagnosis of cervical displasia Page:—
551. The therapeutic value of preoperative neoadjuvent chemotherapy in patients with stage Ⅰ_(B2)~Ⅱ_b bulky cervical cancer Page:—
552. Postoperative radiotherapy for stage Ⅱ/Ⅲ rectal cancer Page:—
553. Analysis of prognostic factors in patients with non-small cell lung cancer treated by surgery and chemotherapy Page:—
554. Effect of NS398 on anti-proliferation and inducing apoptosis of human osteosarcoma cell MG-63 line Page:—
555. Relationship between CD117 expression and chemotherapy effect on the patients with acute nonlymphoblastic leukemia Page:—
556. Angiographic manifestations of hepatocarcinoma after radiofrequency ablation treatment Page:—
557. Clinical study of TEP regimen in the treatment of small cell lung cancer Page:—
558. Detection of hydrothorax or ascites in patients with cancers using immunomagnetic beads technique Page:—
559. Cryotherapy combining with ethanol injection therapy in the treatment of irresec table hepatic cancer Page:—
560. A phase Ⅰ/Ⅱ clinical trial of three dimensional conformal radiation therapy combined with transcatheter arterial chemoembolization for liver cancer Page:—
561. Advances in research on the mechanisms of trastuzumab resistance and strategies to overcome the resistance Page:—
562. Clinical signifi cance of 3 different approaches in the detection of bone marrow involvement in B cell lymphoma Page:—
563. Prognostic predictors for breast cancer patients with brain metastasis after rad iotherapy Page:—
564. Expression of LUNX and CK19 in non-small cell lung cancer and its significance Page:—
565. The value of predicting the axillary lymph node(ALN) metastases status by sentinel lymph node biopsy(SLNB) with methylene blue subcantaneous injection in the breast cancer Page:—
566. Clinicopathologic feature and PRA,PRB expressions of 17 cases uterine malignant mixed mesodermal tumor and their significannce Page:—
567. Continuous infusion of paclitaxel combined with cisplatin in the treatment of advanced non-small-cell lung cancer Page:—
568. Carbonic anhydrase Ⅸ and tumor Page:—
569. Drug induced radiation recall dermatitis Page:—
570. The Primary of single photonemisson computed tomography in diagnosis of multifical pulmonary lesions Page:—
571. Clinicopathological significance of vascular endothelial growth factor C and its receptors in cervical carcinoma Page:—
572. Concurrent chemoradiotherapy with low dose weekly paclitaxel in the treatment of stage Ⅲ non-small-cell lung cancer Page:—
573. Effects of mifepristone on the growth of human endometrial carcinoma cell line HHUA xenografted in nude mice of and the expressions of COX-2,CDK4 Page:—
574. The relationship between new suppressor gene RASSF1 and gastric-carcinoma Page:—
575. Development of targeted therapy on gastroeternaral tumor Page:—
576. Expression of BUB1 and APC protein in different breast tissues and its clinical signifi cance Page:—
577. Clinical study of t-PA and u-PA expression in patients with gastric or intestinal cancer Page:—
578. The significance of abdominal residue after primary cytoreductive surgery forst age Ⅲ ovarian cancer Page:—
579. Cytochrome P450 and tumor Page:—
580. Expression of Epstein-Barr virus gene BARF1 in the nasopharyngeal carcinoma and its significance Page:—
581. Microsatellite analysis of BAT-26 and BAT-25 in nodal non-Hodgkin′s lymphomas Page:—
582. Expression of survivin gene in the dysplasia of gastric mucous epithelium and the gastric carcinoma and its significance Page:—
583. Sleeve resection of bronchus and pulmonary artery for central type lung cancer Page:—
584. The comparison of concurrent chemoradiotherapy with sequential chemo-and radiotherapy for the treatment of patients with stage Ⅲ esophageal carcinoma Page:—
585. Clinical utility of serum tumor markers in mature cystic teratoma of the ovary and its malignant transformation Page:—
586. Clinical and pathological characteristics of benign metastasizing leiomyoma Page:—
587. Clinicopathological changes of renal transplantation related Kaposi's sarcoma Page:—
588. The in vitro study on radiobiological effects of prolonged fraction delivery time Page:—
589. The combination of docetaxel,cisplatin,fluorouracil and leucovorin(CF) as neoadjuvant chemotherapy for the treatment of non-resectable advanced gastric cancer Page:—
590. Research advancement of pancreatic cancer stem cells Page:—
591. Late course accelerated hyperfractionation radiotherapy on selective esophageal carcinoma Page:—
592. Impacts of inhibiting Endostatin on the growth of SKOV_3 cell and it's mechanism Page:—
593. Arsenic trioxide induces gallbladder carcinoma cell apoptosis and study of its mechanism Page:—
594. Progress of clinical medication for esophageal cancer Page:—
595. Advances on DNA methylation for noninvasive tumor molecular diagnosis Page:—
596. Evaluation of surgical treatment of 32 myasthenia gravis patients with thymoma Page:—
597. Inhibitory effects of shRNA targeting Twist on epithelial-mesenchymal transition and invasion ability of human lung carcinoma cell A549 in vitro Page:—
598. Clinical characteristics and prognostic of uterine body invasion of stage Ⅰ_b and Ⅱ_a uterine cervix carcinoma Page:—
599. PSA kinetic parameters in predicting effect of chemotherapy for hormonal refractory prostate cancer Page:—
600. Advances in clinical investigation of adjuvant radiotherapy in rectal cancer Page:—
601. The research on expression and clinical significance of MCM2 in BTCC Page:—
602. Effects of antidiabetic drug metformin on the migration and invasion abilities of human lung adenocarcinoma A549 cell line in vitro Page:—
603. A clinical study in undifferentiated small cell carcinoma of the esophagus Page:—
604. The value of magnetic resonance imaging(MRI) staging in radiotherapy of early prostate carcinoma Page:—
605. The definition and delineation of lymph nodes regions of lung cancer on CT transections Page:—
606. Progress of clinical brachytherapy application Page:—
607. Functional imaging and biological target volume:advances of experimental and clinical research Page:—
608. Progression of treatment in locally advanced breast cancer Page:—
609. Diagnosis,treatments and prognosis of local recurrence of breast cancer after conservative therapy Page:—
610. Progression and study of the catalytic subunit of human telomerase(hTERT) in tumor therapy Page:—
611. The expressions of COX-2 and VEGF-C in stage Ⅱ and Ⅲ rectal cancer and its association with angiogenesis and prognoses Page:—
612. Study on the expression of PTEN and P53 in human primary gallbladder carcinoma(HGC) Page:—
613. The Effects of rhG-CSF on morphology,phenotype and function of neutrophil in patients with malignant lymphoma after the treatment of chemotherapy Page:—
614. The development of FOXO3a in breast cancer Page:—
615. The impact of DOC-2 expression on the tumorigenesis of human ovarian cancer cell line(HO-8910) Page:—
616. miRNA:new microRNA which regulates gene expression Page:—
617. Clinical characteristic and current status of treatment for nasal NK/T cell lymphoma Page:—
618. The significance of dissecting the laryngeal nerve in operation of thyroid tumour Page:—
619. Surgical treatment effects in cancer of the cardia and esophagogastric junction Page:—
620. Inhibition of proliferation on Faji cells by the combination of INF-? and curcumin Page:—
621. Expression of somatostatin receptors in nasopharyngeal carcinoma cell line CNE_2 Page:—
622. Clinical progress of the research on circulating tumor cells in colorectal cancer Page:—
623. Safety issues of sentinel lymph node biopsy in breast cancer Page:—
624. Principle and strategy of clinical practice in adjuvant endocrine therapy for women with early breast cancer Page:—
625. Neoadjuvant endocrine therapy in breast cancer Page:—
626. Research progress on cardiac injury from breast cancer radiation therapy Page:—
627. Clinical research of acupuncture treatment in the prevention of delayed nausea and vomiting induced by NVB and CDDP for the treatment of NSCLC Page:—
628. Study on the effect of brucine on cyclooxygenase 2 in non-small cell lung cancer cells Page:—
629. The impact of 5-Aza-CdR on demathylation of transcription regulation of E-cadherin gene in tumor cell line Page:—
630. Change of survivin gene expression in gastric cancer cell line BGC-823 induced by hydroxycamptothecine Page:—
631. Effect of Rhodiola on nude mice with human breast cancer xenografts Page:—
632. Advances in medical treatment of metastatic colorectal cancer Page:—
633. Advance on the research and clinical treatment of gastrointestinal stromal tumors Page:—
634. Expression of AP-1 subunits in skin tumor and its significance Page:—
635. Inhibitory effect of arsenic trioxide on angiogenesis of chick embryo chrioallantoic membrane Page:—
636. Advance in MR imaging for evaluation of postradiotherapy salivary function in patients with head and neck cancer Page:—
637. Analysis of gene expression difference on cell sublines with different metastatic capabilities from human osteosarcoma and its significance Page:—
638. Docetaxel combined with cisplatin and fluorouracil in the treatment of advanced gastric cancer Page:—
639. Expression of MAD2 and tumor suppressor gene in the colorectal cancer and clinical significance Page:—
640. The feasibility of pancreatoduodenectomy with vascular reconstruction to treat pancreatic and duodenal tumor Page:—
641. HIF-1? expression and its relationship among clinicopathology,P53 and P-gp in gastric carcinoma Page:—
642. Expression and significance of ezrin in human primary sporadic colorectal carcinoma Page:—
643. State-of-the-art multi-disciplinary treatment for advanced gastric cancer Page:—
644. Diagnosis and treatment of gestational trophoblastic neoplasia Page:—
645. Methylation of gene promoter and chemorisistance Page:—
646. Molecular mechanism of TGF-?/EGFR autocrine loop in the regulation of proliferation and metastasis of ovarian cancer cell line Page:—
647. Differential expression of genes in papillary thyroid cancer with lymph node metastasis Page:—
648. Evaluation of the following treatment after cervical conization with positive margins for patients with cervical neoplasm Page:—
649. Expression of catenins and cyclin D1 in poorly differentiated squamous cell carcinoma of nasopharynx and their potentially clinical significance Page:—
650. Comparison of different HPV DNA extraction methods with serum samples from cervical cancer patients Page:—
651. Inhibition of STAT3 expression on chemosensitivity of ovarian cancer cell line SKOV3 Page:—
652. Treatment and prognostic factors for the patients with yolk sac tumors of the ovary Page:—
653. Expression of apoptosis inhibision protein, Survivin,P53,and HPV in cervical carcinomas Page:—
654. Modalities of pelvic autonomic nerve-sparing surgery in pelvis-gynecology Page:—
655. Development of clinical and basic research in gynecological oncology Page:—
656. Application of breast fiberoptic ductoscopy with abnormal nipple secretion(an analysis of 1000 cases) Page:—
657. Advance in the medical treatment of multiple myeloma Page:—
658. Effects of silencing cortactin expression by siRNA on the proliferation and invasion in Hep-2 cells Page:—
659. Advances in research on extranodal NK/T cell lymphoma(nasal type) Page:—
660. Irinotecan plus fuorouracil/ leucovorin as the first-line in treatment of 37 patients with advanced colorectal cancer Page:—
661. Clinical study of docetaxel and capecitabine(xeloda)combination in the treatment of patients with metastatic breast cancer and previously treaded with anthracyslines Page:—
662. Three-dimensional conformal hypofractionated radiotherapy for non-small-cell lung cancer Page:—
663. Expression of endocrine glands-derived-vascular endothelial growth factor in human gastric cancer tissue Page:—
664. Application of XRCC1 gene in cancer research Page:—
665. Memory T cells in tumor immunity Page:—
666. Progress in effects of the HGF/SF-c-Met on progression of tumors and inhibitors of its pathway Page:—
667. Relationship of MGB-2 expression and chemotherapy response and prognosis in human ovarian carcinoma Page:—
668. Cloning of hTERT promoter and its specific transcriptional activity in MCF7 breast cancer cell Page:—
669. Apoptotic effect of RIZ1 expression on human myeloid leukemic cell lines Page:—
670. hMLH1 promoter hypermethylation correlates with platinum-resistance in non-small cell lung cancer cells Page:—
671. Newly interrupted techniques and procedures to prevent gastric cancer cells dissemination in the radical resection of gastric cancer Page:—
672. Elemene emulsion combined with NP chemotherapy in the treatment of advanced NSCLC patients Page:—
673. siRNAs silence expression of mdr1 gene and its role in reversing drug-resistance in K562/ADM cells Page:—
674. Targeted therapy of metastatic renal cell carcinoma Page:—
675. Targeted therapy for colorectal cancer Page:—
676. Targeted therapy of lung cancer-data from Asia Page:—
677. Advances in the targeted therapy of cancer:multi-targeted Raf kinase inhibitor Page:—
678. Incidence of chemotherapy-induced amenorrhea and further endocrine therapy thinking in breast cancer Page:—
679. Paclitaxel administered by weekly infusion combined with hyperthermic intraperitoneal perfusion chemotheraphy with cisplatin in the treatment of 51 patients with advanced gastric cancer Page:—
680. The study of regional cell immune response on ultrasonically guided microwave coagulation therapy for hepatocellular carcinoma and the influence of lymphocytic infiltration on clinical curative effect Page:—
681. The impact of Syk expression on cell apoptosis in gastric carcinoma Page:—
682. Expression of NF-?Bp65,Bcl-2,Bcl-xL and their relationships with expression of P53 proteins and apoptotic index in pancreatic cancer Page:—
683. Inhibition effect of exemestane in endometrial carcinoma cell line HHUA in vitro Page:—
684. Expression of inducible nitric oxide synthase in nasopharyngeal carcinoma(NPC) and its significance Page:—
685. Advances in combined therapy with bladder preservation for invasive bladder cancer Page:—
686. The diagnosis and treatment of adult primary renal sarcoma : 9 cases report and literature review Page:—
687. Expression of KAI-1,Ki-67 and HER-2/neu on T_(1-3)N_0M_0 stage renal carcinoma(RC) and its significance to predict postoperative metastasis of RC Page:—
688. A meta-analysis of comparison of intravesical epirubicin versus bacillus calmette-guerin for prevention of postoperative recurrence of non-invasive bladder carcinoma Page:—
689. The strategies for the treatment of prostate cancer with bone metastases Page:—
690. Diagnosis and treatment for local recurrence and metastasis of patients after radical prostatectomy Page:—
691. Advances of radical prostatectomy Page:—
692. Epidemiological trends of prostate cancer: retrospect and prospect Page:—
693. Postoperative radiotherapy of head and neck squamous cell cancer Page:—
694. Combination of CPT-11 and capecitabine in the treatment of advanced gastric cancer Page:—
695. Concurrent PCF chemotherapy plus radiotherapy for middle and advanced cervical cancer Page:—
696. Effect of NK-104 on NF-?B activated by TNF-? in hepatocellular carcinoma cells Page:—
697. Rab27A is involved in malignant phenotypes in human breast cancer cells by regulating the expression of related genes Page:—
698. Establishment and characterization of a docetaxel-resistant variant of human lung adenocarcinoma cell line SPC-A1 Page:—
699. Phase Ⅰ study of huachansu in hepatocellular carcinoma,non-small cell lung cancer,and pancreatic cancer:a preliminary report Page:—
700. Progress of dose fraction in radiotherapy for non-small cell lung cancer Page:—
701. The function of caveolins in neoplasia and its progressing Page:—
702. Laminin-5 cells stimulate the migration of prostate cancer cells Page:—
703. New developments in gastrointestinal stromal tumor Page:—
704. Nedaplatin combined with radiotherapy in the treatment of advanced nasopharyngeal carcinoma Page:—
705. A randomized clinical study of capecitabine plus oxaliplatin compared with fluorouracil/leucovorin plus oxaliplatin in the treatment of advanced gastric cancer Page:—
706. Clinical study of video-assisted mini-thoractomy surgery for lung tumor with lymphadenectomy Page:—
707. The correlation between hEST2 reverse transcription motif and the activity of telomerase Page:—
708. Ifosfamine and etoposide in 26 cases with relapse ovarian carcinoma Page:—
709. Loop electrosurgical excision procedure for treatment of CINⅢ and cervical carcinoma stage Ⅰ_(A1) Page:—
710. Whether the hepatitis B virus envelope as a gene transfer vector has targeting ability for liver cancer Page:—
711. Comparison of intensity-modulated and three-dimensional conformal techniques for radiotherapy of esophageal carcinoma Page:—
712. Modified three-weeks' docetaxel/cisplatin as first line chemotherapy for advanced non-small cell lung cancer Page:—
713. Prognostic factor analysis of 603 cases with gastric cancer undergoing radical resection Page:—
714. Treatment of olfactory neuroblastoma with surgery plus irradiation——a report of 14 cases Page:—
715. Expression of death-associated protein kinase 1 in papillary thyroid carcinoma Page:—
716. Effect on radiation-induced apoptosis of HeLa cells by inhibiting expression of NF-?B Page:—
717. The effect of TFPI-2 gene on apoptosis of pancreatic cancer cell Page:—
718. Apoptosis of nasopharyngeal cancer cells line CNE2 induced by diallyl disulfide and its possible molecular mechanism Page:—
719. Differential diagnosis between the proliferative Kikuchi lymphadenitis and malignant lymphoma Page:—
720. Comparative study on P53 mRNA in colorectal tumor paraffin embedded samples by RT PCRIS Page:—
721. The study of immunoglobulin heavy-chain gene rearrangement in diffuse large B-cell lymphoma using fluorescence quantitative PCR Page:—
722. Study on the gene expression profile of poorly differentiated gastric carcinoma using cDNA microarray Page:—
723. The value of inducible nitric oxide synthase to select the project of treatment in nasopharyngeal carcinoma Page:—
724. Interference for recurrence of hepatocellular carcinoma after liver transplantation Page:—
725. The relationship between neuroendocrine differentiated prostate carcinoma and drug-resistance to endocrine therapy Page:—
726. Advances of the research in gene therapy for prostate cancer Page:—
727. Detection on the expression of PKC-? protein in lung cancer by tissue microarray Page:—
728. Prognostic factors of epithelial ovarian carcinoma in patients with age under 40 Page:—
729. Palliative resection of advanced gastric cancer Page:—
730. The investigation of high risk type human papillomavirus prevalence and incidence rates of cervical intraepithelial neoplasia in Shenzhen women with different screen Page:—
731. Treatment of advanced gastric cancer with the regimen of etoposide,folinic acid and fluorouracil Page:—
732. Comparison and analysis of the operation approach of esophageal carcinoma Page:—
733. Analysis on the CT findings of benign and malignant parotid tumors Page:—
734. Advances in the diagnosis and management of pregnancy associated breast cancer Page:—
735. Advances in the study of carcinoma-associated fibroblasts Page:—
736. Advances in the application of quantum dots in tumor markers investigation Page:—
737. Biological effects of connective tissue growth factor transfection on human breast cancer cells Page:—
738. Effects of Tiam 1 antisense oligodeoxynucleotides transfection on the invasive and migratory potentials of gastric cancer cells in vitro and vivo Page:—
739. A randomized controlled clinical trial on irinotecan/cisplatin versus gemcitabine/cisplatin as the first-line treatment in advanced non-small cell lung cancer Page:—
740. Committed differentiation of CD34~+ hematopoietic progenitor cells Page:—
741. Relationship between the expression of vascular endothelial growth factor and the prognosis of colon cancer patients Page:—
742. Expression of thymidylate synthase and thymidine phosphorylase in gastric cancer and their correlation with prognosis Page:—
743. Preliminary study of aspisol inhibition on proliferation of breast cancer cells Page:—
744. Let's usher in a new era in lung cancer studies——The 12th World Conference on Lung Cancer Commentary Page:—
745. Effect and significance of TGF-?1 in the process of radiation fibrosis Page:—
746. New developments in advanced non-small cell lung cancer Page:—
747. The antitumor treatment with anaerobic bacteria exploiting hypoxia Page:—
748. Preoperative assessment of cervical invasion in endometrial cancer:comparison of MRI and D&C Page:—
749. Study for the effect of the treatment for the clear-cell cancer of the ovary Page:—
750. Expressions and clinical significance of HIF-1? and multidrug resistance genes in human colorectal adenocarcinoma Page:—
751. Effects of hTERT siRNA on expression of hTERT and repression of cell growth in breast cancer cells Page:—
752. Arsenic trioxide inhibits the growth of human gall bladder carcinoma cell and its effect on the cyclin D1 Page:—
753. Advanced non small cell lung cancer treated with gemcitabin combined with cisplatin Page:—
754. Expression of E-cadherin and nm23 in papillary thyroid carcinoma and its clinical significance Page:—
755. Inhibitory effects of norcantharidin on angiogenesis of human breast carcinoma Page:—
756. Inhibitory effect of recombinant human endostatin combined with rAd/p53 on graft model of human breast cancer in nude mice Page:—
757. The diagnostic of six cases with gastric submucosal tumor Page:—
758. Clinical application of CyberKnife for the treatment of intracranial and extracranial tumors Page:—
759. Pentamidine sensitizes leukemia K562 cells to TRAIL-induced apoptosis Page:—
760. Construction and identification of psilencer3.0-HIF-? siRNA Page:—
761. Effects of triiodothyronine on estrogen receptor-? and thyroid hormone receptor-? in breast cancer cells Page:—
762. The effects of Ad-p53 on the reversal of multidrug resistance in human breast cancer cell line and its impacts on the expressions of P-gp,TOPOⅡ and GST-? Page:—
763. Benign glandular schwannoma Page:—
764. Polymorphism of Duffy blood group phenotypes and breast cancer in Chinese female breast disease patients of Han population Page:—
765. Preliminary results of locally recurrent nasopharyngeal carcinoma treated with intensity modulated radiation therapy Page:—
766. Screening of DOC-2 interactive proteins and identification of the interaction between DOC-2 and TGF?Ⅲ receptor Page:—
767. Experimental intraperitoneal continuous chemotherapy on human ovarian epithelial cancer in nude mice Page:—
768. Advances in the experimental and clinical research of pemetrexed Page:—
769. Modified radical mastectomy-stage Ⅰ expansion of latissimus dorsi muscle flap breast reconstruction Page:—
770. Surgical management and prognostic analysis on recurrent colorectal carcinomas Page:—
771. Weekly and three-weeks' docetaxel,cisplatin and 5-FU treatment in advanced gastric carcinoma Page:—
772. Establishment of 451 bp fragment that functionally related to transportation in hepatocellular carcinoma supressor gene-1(HCCS1) Page:—
773. The effect of Smac/DIABLO associating with Survivin shRNA on the cell growth and apoptosis of Lovo Page:—
774. The difference and relationship of gene expression profiles between gastric cancer and chronic atrophic gastritis Page:—
775. Diclofenac sodium extended-release capsule for cancer pain in senile patients Page:—
776. Mutations in BRCA1 and BRCA2 in sporadic cases with breast cancer in eastern China Page:—
777. Signal pathway of CYLD and tumor Page:—
778. Histogenesis,differential diagnosis and prognosis of melanotic schowannoma Page:—
779. Apoptotic susceptibility of the tumor cells to arsenic trioxide is associated with the inherent level of cellular reactive oxygen species Page:—
780. Therapy for small cell lung cancer:review and prospect Page:—
781. Advances in effects and mechanisms of ADAMs in tumor progression Page:—
782. The effect of traditional Chinese medicine therapy on serum CA-125 in lung cancer patients Page:—
783. Isolation and purification of breast cancer stem cells by suspension culture combined with chemotherapeutic agents Page:—
784. Advances on esophageal carcinoma radiotherapy in China Page:—
785. The research on composite radix sophora flavescentis injection combined with oxaliplatin inhibiting angiogenesis Page:—
786. New series of WHO classification of tumors Page:—
787. Advances in breast cancer clinical research Page:—
788. The research on the relationship between CD44,CYP2E1 genetic polymorphisms and esophageal cancer Page:—
789. Resection of retroperitoneal tumors with reconstruction of major blood vessels in 12 patients Page:—
790. Progress in CXCL12-CXCR4 biological axis in colorectal cancer Page:—
791. Research avancement of breast cancer and hypoxia-inducible factor-1 Page:—
792. The research progress of carcino-embryonic antigen related cellular adhesion molecule 1 Page:—
793. C-erbB-2-future biological marker of breast cancer chemotherapy Page:—
794. Combined measurement of serum CYFRA21-1,NSE,CEA,CA19-9,CA125 and SCC:diagnosis value to lung cancer Page:—
795. Malignancy with immune thrombocytopenia Page:—
796. Application of intravesical ureterectomy in the treatment of renal pelvic and ureteral malignancy Page:—
797. Effect of combination of TRAIL and paclitaxel on human gastric cancer cell line SGC7901 Page:—
798. Effect of CD133~+ stem cells from cord blood on the proliferation,adhesion and migration in human colorectal neoplasm cell line SW480 Page:—
799. Treatment of malignant pleural effusion using S_(311) anticancer vaccine by intrapleural injection Page:—
800. Accurate radiotherapy for esophageal cancer Page:—
801. Role of cell adhesion molecules in bone metastasis of tumor Page:—
802. The evaluation of whole-body bone scanning in detecting bone metastases in patients with lung cancer Page:—
803. Estrogen promotes ER positive breast cancer cell growth with up-regulating chemokine CXCL12 Page:—
804. Expression of heat shock protein 70 and infection of human papillomavirus in penis carcinomas Page:—
805. Current trends in extended lymph node dissection for thoracic esophageal carcinoma:Evidence and experience Page:—
806. Adenocarcinoma of esophagogastric junction:concept and strategy Page:—
807. The impact of radiotherapy on breast reconstruction Page:—
808. Clinical observation on irinotecan as second-line treatment of patients with advanced colorectal carcinoma Page:—
809. Clinical effi ciency of pemetrexed in the treatment of advanced retreated non-small cell lung cancer Page:—
810. Randomized study of docetaxcel plus cisplatin versus gecitabine plus cisplatin in treatment of advanced non-small cell lung caner Page:—
811. Jian Pi Li Qi Herbs(JH) up-regulate nm23 Page:—
812. The effect of preoperative chemotherapy in stage Ⅰ_(b2) cervical cancer Page:—
813. Effect of antineoplastic polypeptide from Buthus martensii venom on human tumor cell lines and animal transplanting tumors Page:—
814. The clinicopathological analysis of gastrointestinal stromal tumors with hepatic metastasis and a review of literature Page:—
815. The effect of carboplatin, on fractional dissection form, combined with X-ray on the immune function of the Lewis lung cancer Page:—
816. Research advancement of prostate cancer stem cells Page:—
817. Advances in the research of the effects of tea polyphenols in cancer prevention and treatment Page:—
818. Treatment and prognostic factors of primary colorectal non-Hodgkin's lymphoma Page:—
819. Biological behavior of gastric cancer as a guide for choosing type of operation Page:—
820. Ondansetron plus dexamthasone in anti-emesis induced by cisplatin containing chemotherapy Page:—
821. The incidence of nipple-areola complex(NAC) involvement in breast cancer patients and the feasibility of NAC sparing mastectomy Page:—
822. The expression and significance of the multidrug resistance-related proteins P-gp, MRP, LRP and GST-? in lung cancer using tissue microarray Page:—
823. Diagnostic value of Mini-laparoscopy in abdominal neoplasmas Page:—
824. Inhibitory effect of paclitaxel combined with nedaplatin on HeLa cells transplanted in nude mice Page:—
825. Lymphomatoid papulosis,type C:1 case report and literature review Page:—
826. Advances in the treatment of parotid gland adnoid cystic carcinoma Page:—
827. Research on chemoradiotherapy of nasopharyngeal carcinoma Page:—
828. Advance in the clinical research on local recurrent nasopharyngeal carcinoma Page:—
829. Expression of nm23 protein in human breast carcinoma and their clinical significance Page:—
830. Study progress of tumor marker related to nasopharygeal carcinoma Page:—
831. Advance on staging system of nasopharyngeal carcinoma Page:—
832. Expression of tansforming growth factor-? and tansforming growth factor-? receptor in colorectal adenocarcinoma Page:—
833. The historical evolution of diagnosis and radiotherapy for nasopharyngeal carcinoma Page:—
834. Expression and significance of the mRNA and protein of Multiple tumor suppressor 1(MTS_1) in gastric cancer and its precancerous lesions Page:—
835. The clinical significance of urine NTX,serum BAP in multiple myeloma Page:—
836. Combinational effects of bcl-2 antisense oligodexynucleotide with arsenic trioxide on malignant lymphoma cell lines Page:—
837. Anti-tumor and immunoenhancement effects of effective combination of extraction from edible fungi on C26 xenograft mice Page:—
838. Advance in the study of ?1,3 fucosyltransferase Ⅶ and glycoprotein CD24 in tumor metastasis Page:—
839. Weekly docetaxel combined with oxaliplatin in the treatment of advanced gastric cancer Page:—
840. The expression of SPARC in hepatocellar carcinoma and its significance Page:—
841. Clinical analysis of 16 cases with olfactory neuroblastoma Page:—
842. Interference of Yiqijiedu formula in DNP inducing effects on the occurrence of precancerous lesions of nasal and nasopharyngeal epithelia in TgN(p53mt-LMP1)/HT transgenic mice Page:—
843. The toxic reactions of all-trans retinoic acid occuring in the treatment of acute promyelocytic leukemia Page:—
844. Hypoxia-induced apoptosis and anti-apoptosis in ovarian cancer cell line SKOV-3ipl cells and its correlation with cell cycle Page:—
845. Retrospective analysis of the relation between the clinical features and prognosis of 12 solitary plasmacytoma of bone patients Page:—
846. The effect of gefitinib on the quality of life in patients with advanced non-small cell lung cancer Page:—
847. Expression of telomerase activity in peripheral blood of patients with lung cancer Page:—
848. A comparison between gemcitabine-based combination chemotherapy and gemcitabine alone on advanced pancreatic cancer:a Meta-analysis in phase Ⅲ clinical trials Page:—
849. Genetic diagnosis of occult metastasis of lymph node in patients with esophageal carcinoma Page:—
850. Effect of peripheral blood lymphocyte subsets and prognosis in autologous LAK cell treatment of advanced lung adenocarcinoma Page:—
851. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix Page:—
852. The patterns of cervical lymph node metastatic squamous cell carcinoma from different primary sites of head and neck cancers Page:—
853. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer Page:—
854. The clinical characteristics and prognostic factors of breast carcinoma in women aged 25 years or less Page:—
855. Contrast analysis of breast cancer and benign lesion with FCM Page:—
856. Analysis of 21 cases with intrathoracic angiofollicular lymphoid hyperplasia Page:—
857. The relative parameters of liver metastasis of colorectal carcinoma after surgery Page:—
858. Clinical study of major pulmonary resection by video-assisted mini-thoractomy for patients with lung cancer Page:—
859. The evidence-based adjuvant chemotherapy for colon cancer Page:—
860. Early detection of breast cancer with microcalcification but without palpable mass Page:—
861. Clinical analysis of combined esophageal stent inserting with three-dimensional conformal radiotherapy and concurrent chemotherapy on esophageal carcinoma Page:—
862. Effects of antidiabetic drug metformin on human lung adenocarcinoma cell A549 proliferation and apoptosis in vitro Page:—
863. Expression of Survivin,Caspase-3 and Bcl-2 in lung carcinoma Page:—
864. Protective effects of glutamine for the morphological and functional damage of gastrointestinal mucosa induced by introperitoneally 5-FU in rats Page:—
865. Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple negative breast cancer Page:—
866. Recombinant human erythropoietin in the treatment of cisplatin-based-chemotherapy-induced a-nemia Page:—
867. Protein expressions of multi-gene for predicting the prognosis of early breast cancer with COX model analysis Page:—
868. Therapeutic effects of percutaneous alternating cryogenic-heating therapy for nonresectable hepa-tocellular carcinoma Page:—
869. Oxaliplatin combined fluorouracil and calcium folinate in the treatment of 37 cases with advanced colorectal cancer Page:—
870. Continuous vs intermittent infusion of fluorouracil in advanced colorectal cancer Page:—
871. Effect of thalidomide combined with PC regimen on efficacy/serum VEGF in patients with non-small cell lung cancer Page:—
872. Evaluation of EMMPRIN(CD147) expression in cervical cancer:a critical role in development and progression Page:—
873. Surgical treatment for 27 cases of malignant fibrous histiocytoma in the soft tissue of the neck Page:—
874. Distribution of human papillomavirus and its subtypes in tissue samples of Uigur cervical cancer from southern Xinjiang Page:—
875. The effect of three dimensional conformal radiation therapy for 34 cases of children medulloblastoma Page:—
876. Influence of high dose progesterone on telomerase activity in patients with carcinoma of endome-trium Page:—
877. The effects of heat shock protein 90 inhibitor 17-AAG on the proliferation and cell cycles of LoVo cells Page:—
878. Metastatic carcinoma to the uterine cervix from the gastric and the colorectal:A study of 22 cases Page:—
879. Expression of cyclooxysenase-2 in lymph node negative breast cancer lead to perfect the simple prognostic model Page:—
880. The inhibition of endostatin on tumor growth and metastasis of lung cancer in nude mice Page:—
881. Relationship between expression of Kiss-1 and nm23 and lymph node metastasis in breast cancer Page:—
882. The current treatment for brain metastases from breast cancer Page:—
883. Advances on LKB1 in the study of lung cancer Page:—
884. The value of bile CEA assay in detection of liver metastasis in patients with colorectal cancer Page:—
885. Clinical advancement of aromatase inhibitors in the therapy for human breast cancer Page:—
886. Relation of expression of survivin and BCRP gene in prediction of response to chemotherapy in metastatic breast cancer Page:—
887. Clinical observation of temozolomide combined with radiotherapy for 18 cases of newly diagnosed high grade gliomas Page:—
888. Adjuvant therapy in patients with uterine sarcomas Page:—
889. Hydroxycamptothecine plus oxaliplatin compared with fluorouracil/leucovorin (LV5FU2) plus oxaliplatin in the treatment of metastatic colorectal cancer:a randomized clinical study Page:—
890. An evaluation on effect and safety of morphine sulfate controlled-release tablet combined with celecoxib for the treatment of moderate to severe cancer-induced pain Page:—
891. Non-operative treatment of patients with stageⅠandⅡnon-small-cell lung cancer Page:—
892. Change expressing of hTERT gene in breast cancer tissue before and after neo-adjuvant chemotherapy Page:—
893. The molecular mechanism of lymphangiogenesis and lymphatic metastasis of malignant tumors Page:—
894. The characteristics of thoracic stomach cancer after surgical treatment for esophageal carcinoma Page:—
895. Surgical treatment for 46 patients with pulmonary metastases and regressive analysis of related prognostic factors Page:—
896. The comparision between two international QOL questionnaire of lung cancer:EORTC QLQ-LC43 and FACT-L Page:—
897. Effect of 5-aza-2’-deoxycytidine on MEG3 gene expression and proliferation of human mammary cancer line MCF7 Page:—
898. Expression of cyclin D1,p53 and c-myc genes and the biological behavior of gastric carcinoma Page:—
899. The impacts of epirubicin and liposome doxorubicin on human breast cancer cell lines and dentritic cells Page:—
900. Effect of hypoxia on human small cell lung cancer cell line H446 Page:—
901. Expression of COX-2,p53 and PCNA in esophageal carcinoma and its significance Page:—
902. Expression and clinical signifi cance of Mel-18 mRNA in gastric carcinoma Page:—
903. Association of BRCA1-related DNA repair genetic variations and high incidence of metastasis in triple-negative breast cancer Page:—
904. Genetic polymorphisms of p53 codon72 and the risk of gastric cancer-case-control study Page:—
905. The investigation of the clinical characteristics and surgery on Hashimoto’s disease coexistent with thyroid neoplasm Page:—
906. Advances on the study of sentinel lymph node in gastric cancer Page:—
907. Clinical analysis of 64 patients with hepatitis C virus-related hepatocellular carcinoma Page:—
908. Clinical observation on recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in solid tumor patients Page:—
909. The clinical and pathological study in moulding operation about breast cancer Page:—
910. Preliminary observation of pemetrexed combined with cisplatin in the treatment after the treatment failure of anthracycline and taxane in advanced metastatic breast cancer Page:—
911. Radiotherapy and chemoradiotherapy in patient with N1 esophageal carcinoma Page:—
912. The value of high frequency color doppler ultrasound diagnosis for breast intraductal papilloma Page:—
913. Detection of hMLH1/hMSH2 expression for identifying patients with hereditary non-polyposis colorectal carcinoma Page:—
914. A study on expression of BRCA1 gene in sporadic ovarian epithelial cancer in China Page:—
915. The study of DNA content and cell proliferation during the course of development of golden hamster buccal pouch carcinoma Page:—
916. An experimental study of rh-endostatin in combination with radiation on human lung adenocarcinoma A549 cell in mice Page:—
917. Comparison of clinical effects of butorphanol and flurbiprofen axetil combined with sufentanil on patients by controlled intravenous analgesia after the surgery of gynecological tumor Page:—
918. Expression and significance of PC5,PC7,VEGF-C,VEGF-D and VEGFR-3 mRNA in non-small cell lung cancer Page:—
919. Endoscopic analysis of the ~(18)F-FDG accumulations in gastrointestinal tract after PET-CT examinations Page:—
920. Study on the effect of down-regulation of DNMT1 on cell proliferation,metastasis ability of esophageal squamous cell carcinoma cell line EC9706 cells and its related mechanisms Page:—
921. Relationship between expression of Twist and KiSS-1 and progonosis in non-small cell lung cancer Page:—
922. Effects of X-ray irradiation combined with RNAi against STAT3 on proliferation and apoptosis of human esophageal carcinoma cells Page:—
923. Studies on mass survery of 413164 persons for NPC Page:—
924. Inhibition of activation of NF-?B enhanced apoptosis induced by cytosine arabinoside in leukemic cells Page:—
925. Combination of docetaxel and capecitabine in the neoadjuvant chemotherapy of breast cancer Page:—
926. Comparative study on gene expression difference between high and low metastatic human hepatocellular carcinoma cell strains Page:—
927. Advances on novel estrogen receptor GPR30 Page:—
928. Current status of targeting antiapoptotic gene by antisense oligodeoxynucleotides Page:—
929. Chk1 gene scilencing potentiates human hepatoma Huh7 cells to curcumin-induced apoptosis Page:—
930. Fumagillin inhibits colorectal cancer growth and metastasis in mice:an in vivo and in vitro study of antiangiogenesis Page:—
931. Application of peritoneal non-closure technique in radical surgery of cervical carcinoma Page:—
932. Intraabdominal infusion of paclitaxel in treating malignant ascites of gastric cancer:report of 6 cases Page:—
933. Comparative clinical study on preoperative intra-arterial infusion chemotherapy for advanced gastric cancer Page:—
934. Research progress on target therapy in advanced non-small cell lung cancer Page:—
935. Molecular imaging probes for integrin ?_V?_3 Page:—
936. Methylprednisolone plus ondansetron for the control of acute and delayed cisplatin-induced emesis Page:—
937. Research progresses on relationship between Wnt inhibitory factor-1 and tumor Page:—
938. Late course accelerated hyperfractionation radiotherapy combined with chemotherapy for elderly patients with esophageal carcinoma Page:—
939. Monitoring of tissue polypeptide specific antigen in the treatment for advanced cancers and its significance Page:—
940. The clinical efficacy of capecitabine administrated continuously for three weeks in treating old patients with advanced digestive tract cancer Page:—
941. Suppression of human glioblastoma in nude mice by siRNA Notch-1 gene therapy Page:—
942. Role of p38MAPK in mediating TNF-?-induced apoptosis in rat glioma cells Page:—
943. Genetic polymorphisms of methionine synthase,methylation of CHD5,and their association with breast cancer mobidity Page:—
944. Construction and expression of anti-CD3?anti-CD19 bispecific diabody and analyzing its specific binding activity Page:—
945. Correlation between patient′s age at onset of sporadic colorectal cancer and microsatellite instability in cancer tissues Page:—
946. The role of magnetic resonance spectroscopy imaging in tumor volume definition and clinic evaluation of radiation therapy Page:—
947. Concurrent chemoradiotherapy followed by adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma Page:—
948. The role of reactive oxygen species in epigallocatechin-3-gallate-induced apoptosis of human gastric cancer MGC803 cells Page:—
949. Research advances in drug resistance markers in non-small cell lung cancer Page:—
950. In vitro cytotoxity and reversal effects of PHⅡ-7 in human multidrug-resistant breast cancer MCF-7/ ADR cells Page:—
951. Advancement of target therapy in endometrial cancer Page:—
952. Isolation and identification of small cell lung cancer stem-like cells Page:—
953. Relationship between standard uptake value of ~(18)F-FDG PET/CT and overexpression of glucose transporter-1 and proliferating cell nuclear antigen in nasopharyngeal carcinoma Page:—
954. The prognostic factors of non-Hodgkin's lymphoma in nasal cavity Page:—
955. Expression of site-specific markers of brain metastatic carcinoma and its significance Page:—
956. Analysis of clinicopathologic features and prognosis-related factors in triple-negative breast cancer Page:—
957. Significance of p53 and C-erbB-2 expression in endemic and AIDS-related Kaposi’s sarcoma in Africa Page:—
958. Integrin alpha v regulates anchorage-independent growth and survival in squamous cell carcinoma cells Page:—
959. Value of different biological markers in prediction of response to neoadjuvant chemotherapy in breast cancer Page:—
960. Expression and clinical pathological significance of E-cadherin and ?-catenin in esophageal squamous cell carcinoma Page:—
961. Expression of nm23 mRNA,p16 in human lung cancer and their significance on tissue microarray Page:—
962. The effect and mechanism of murine serum amyloid A 1,2,3,4 on metastasis of Lewis lung carcinoma cell lines Page:—
963. EML4-ALK fusion oncogene and non-small cell lung cancer Page:—
964. Some problems of operative criterion of lung cancer Page:—
965. Indication and advances of extended resection of locally advanced lung cancer Page:—
966. Expression and clinical significance of vascular endothelial growth factor and epidermal growth factor in non-small cell lung cancer Page:—
967. New application of molecular target for lung cancer Page:—
968. Oophorectomy combined with exemestane treating advanced refractory breast cancer Page:—
971. Relations between human papilloma virus infection and head and neck cancers Page:—
972. Advances of research on realted gene of gastric carcinoma Page:—
973. Angiogenesis research and its progresses in the field of hepatocellular carcinoma Page:—
974. A dosimetery study on different irradiation technique for esophageal carcinoma by 3 dimensional treatment planning system(3D-TPS) Page:—
975. Combining chemotherapy and TCM recipe “Xiao Zheng Fang” for advanced colorectal cancer Page:—
976. Value of ~(99m)Tc MIBI scintimammography in the differential diagnosis betwwen benign breast tumor,breast cancer and lymph node involvement Page:—
977. Mitoxantrone,fluorouracil and leucovorin in the treatment of 41 cases with metastatic breast cancer Page:—
978. Dosimetrical optimization study of intensity modulated radiotherapy for intact breast Page:—
979. The analysis of the relationship between the clinical effect,pathological changes and the neoadjuvant chemotherapy containing THP and docetaxel on breast cancer Page:—
980. Effect of exogenous P14ARF gene on the growth of human glioma cells Page:—
981. The influence of siRNA targeting LMPI gene on expression of AP-1 and its related factors Page:—
982. Relationship between genetic polymorphism of VEGF and risk factor to lung cancer Page:—
983. Experiment of promoting chemosensitivity of bladder cancer cell by synthetic Smac peptide Page:—
984. High dose epirubicin containing combination regimen in the treatment of advanced breast cancer Page:—
985. The clinical diagnosis of prostatic cancer (report of 161 cases) Page:—
986. Low dose fluorouracil and cisplatin continuous infusion for the treatment of advanced gastric carcinoma Page:—
987. Changes of preoperative and postoperative NK and T lymphocyte with gastric cancer Page:—
988. A comparison of the effects of three chemotherapy regimens for advanced non small cell lung cancer Page:—
989. The role of CK7 monoclonal antibodies in indentification of primary and metastatic malignant ascites due to ovarian carcinoma Page:—
990. The role of interleukin 6 and interleukin 6 receptor in gliomas Page:—
991. The role of dendritic cells mediated antitumor immunity in esophageal carcinoma Page:—
992. Etiological role of Val384Asp in hMLH1 gene in gastric and esophageal cancers Page:—
993. Sentinel lymph node biopsy in breast cancer using radiolabeled sulphur colloid Page:—
994. Advances in the research on relationship between p27Kip1 and digestive tumors Page:—
995. The activity of gemcitabine in advanced non-small-cell lung cancer Page:—
996. Factors relating to cross infection in hospital of cancer patients Page:—
997. Expression and clinical significance of nm23-H_1 and nm23-H_2 in human breast cancer Page:—
998. Epidemiological study of the influence of drinking green tea on gastric cancer and chronic gastritis incidence Page:—
999. Quantitative parameters on nuclear DNA of ovarian mucinous cystadenomatous in differential diagnosis Page:—
1000. Application of duct endoscopy in the early diagnosis of breast cancer with nipple discharge Page:—
1001. Influence of arsenic bisulfide on the expression of HSP70 in K_(562)/ADM cell Page:—
1002. Effects of NOEY2 transfection on the growth of human breast cancer cell line Page:—
1003. Relationship between Fas/FasL expression and apoptosis of colon adenocarcinoma cell lines Page:—
1004. Effect of elemene emulsion on gene expression of telomerase catalytic subunit in HeLa cell Page:—
1005. Advances in biological markers on prognosis of esophageal cancer Page:—
1006. Advances in research of the relationship between ectopic hCG and malignant tumor Page:—
1007. Dendritic cells activated by tumor antigen to treat bladder tumor in mouse Page:—
1008. Comparison of the results between two radiotherapeutic methods for cervical cancer patients Page:—
1009. A study on the expression of carcinoembryonic antigen mRNA in tissues specimens by reverse transcription polymerase chain reaction in patients with digestive tract carcinoma Page:—
1010. Three different dividing dosage of DDP combined with chemotherapy to treat moderate and advanced tumors Page:—
1011. Pathogenicity and treatment of acute respiratory distress syndrome following lung cancer surgery Page:—
1012. Expression and clinical significance of bcl-2 gene in breast cancer Page:—
1013. Clinical analysis of chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma Page:—
1014. Navelbine plus cisplatin in the treatment of advanced non-small cell lung cancer Page:—
1015. Continuous infusion of navelbine with cisplatin for management of advanced or metastatic non small cell lung cancer and breast cancer Page:—
1016. Clinical management of functional delayed gastric emptying after colonic operation Page:—
1017. The papeuticcurative effect analysis on malignant tumor of lung transference Page:—
1018. Effect of single lung ventilation for pneumoresection on blood gas Page:—
1019. Induction chemotherapy followed by radiotherapy and radiotherapy alone in patients with advanced nasopharyngeal carcinoma Page:—
1020. The antitumor efficacy of Heplipin on S37 sarcoma and B16 melanoma in mice Page:—
1021. Expression of PCNA、p53、C-erbB-2 in colorectal carcinoma and its relationship with host immune reactions Page:—
1022. The relationship between the infection of Helicobacter pylori in gastric mucosa and the gastrocarcinogenesis in Changle city Page:—
1023. Scorpion venom injection for treatment of cancer pain Page:—
1024. Loss of heterozygosity on chromosome 6 in glioblastoma Page:—
1025. Analysis of the relationship between the cell cycle related factors and carcinogenesis of breast cells and biological characteristics of breast cancer cells Page:—
1026. Relationship between chromosomal translocation and synovial sarcoma Page:—
1027. Advances in diagnosis and treatment of hereditary nonpolyposis colorectal cancer Page:—
1028. Advances in diagnosis and management of breast premlignant disease Page:—
1029. Treatment and prognostic factors in 74 patients with maxillary sinus carcinoma Page:—
1030. Expression of telomerase and p53,p16 genes and its significance in non-small-cell lung cancer Page:—
1031. Regularity of lymph node metastasis in 100 patients of thoracic esophageal carcinoma Page:—
1032. Recurrent epithelial ovarian carcinoma: combined treatment and prognostic factors Page:—
1033. Loss of heterozygosity at chromosome 3p14 and 3p25 in epithelial ovarian tumor Page:—
1034. Progress of clinical application of monoclonal antibodies in the treatment of cancer Page:—
1035. Advances in research on prognostic factors of breast cancer Page:—
1036. From simple superfical X ray machines to intensity modulated radiotherapy: brief introduction for the Department of Radiation Oncology of the Cancer Hosptial of Fudan University Page:—
1037. Outcome and reproductive function after conservative surgery for borderline ovarian tumors Page:—
1038. A novel marker and therapeutic target of breast cancer HER2 and trastuzumab Page:—
1039. Advances in the study of relationship between trace elements and drug resistance of tumor Page:—
1040. Intracavitary hyperthermia combined with radiochemotherapy for esophageal carcinoma Page:—
1041. Effect of combined chemotherapy including Navelbine in the treatment of 39 cases of advanced non-small cell lung cancer Page:—
1042. The clinical outcome of childhood malignant lymphoma with bony erosion Page:—
1043. Clinical analysis of 10 patients with pleural mesothelioma in surgical treatment Page:—
1044. Comparative study of domestic made or imported vinorelbine plus cisplatin combination chemotherapy in non-small-cell lung cancer Page:—
1045. Effects of DDP with cisplatin by CHPP on patients with late digestive tract cancer Page:—
1046. Calcium folinate, 5-fluorouracil bolus and continuous infusion combined with cisplatin in advanced esophageal carcinona Page:—
1047. Study on the mode of operation for post-radiotherapy esophageal carcinoma Page:—
1048. Expression of TopoⅡ gene in human bladder cancer multidrug-resistant cells Page:—
1049. Prognostic factors in bilateral breast cancer Page:—
1050. The relation between nm23-H_1 protein expression or DNA ploidy and lymph node metastasis of esophageal squamous cell carcinoma. Page:—
1051. Pharmacokinetics of intraperitoneal chemotherapy for ovarian cancer Page:—
1052. Primary extragonadal seminoma(report of five cases and review of literature) Page:—
1053. Change of mitochondria membrane potential of HL-60 cells induced by horseshoe crab hemocyte peptides Page:—
1054. Experimental study on inducing apoptosis of tumour cells by protamine inhibiting angiogenesis Page:—
1055. Advances in the relationship of mucins to gastric cancer Page:—
1056. Advances in multidrug resistance mechanisms in lung cancer Page:—
1057. Advances in the research of release and activation of matrix metalloproteinases Page:—
1058. Management of 33 cases with supraglottic carcinomas stage T3 Page:—
1059. Irinotecan in 14 cases wtih advanced colorectal cancer as second-line treatment Page:—
1060. Paclitaxel and platinum-containing chemotherapy in 16 cases with advanced epithelial ovarian cancer Page:—
1061. Radiation therapy and concomitant weekly paclitaxel for locally advanced nasopharyngeal carcinoma: outcomes of a phase I trial Page:—
1062. Biweekly regimen of high-dose leucovorin, fluorouracil and oxaliplatin for advanced and refractory colorectal cancer Page:—
1063. Combination of gemcitabine and cisplatin in the treatment of patients with non-small-cell lung cancer Page:—
1064. Significance of VEGF investigation in combination with SccAg in patients with cervical carcinoma Page:—
1065. Clinical and pathological significance of transforming growth factor ?1 and its related receptors expressed in human bladder transitional cell carcinomas Page:—
1066. Expression of resistance-related genes in lung carcinomas tissue and its clinical significance Page:—
1067. Correlation between expression of CD44V6,E-cadherin and biological behavior in breast cancer Page:—
1068. Growth-suppressing effects of sodium butyrate on human ovarian carcinoma KK cells and endometrial carcinoma HHUA cells Page:—
1069. Effects of human gastric cancer cell line SGC-7901 by p21~(WAF1/CIP1)gene transduction plus cisplatin Page:—
1070. Construction of mammalian co-expression plasmid pIRES-CEA-IL-2 and its expression in vitro Page:—
1071. Cyclins/CDKs and antitumor activity of their inhibitors Page:—
1072. The activated endothelial cells serve as target in tumor treatment Page:—
1073. Advances in the research on the STK11 gene Page:—
1074. Management of chylothorax after pulmonary resection Page:—
1075. Evaluation of intravenous and intraperitoneal chemotherapy in advanced gastric cancer Page:—
1076. Clinical analysis of preoperative diagnostic methods in small sized lung cancer (≤3 cm) Page:—
1077. The diagnosis and treatment of urachal carcinoma(Report of three cases and literature review) Page:—
1078. Expression of uPA,uPAR,PAI-1 in three nasopharyngeal carcinoma cell(NPC) lines with different ability to metastasize Page:—
1079. Hepatoid adenocarcinoma of the stomach: report of 3 cases and review of the literature in recent ten years Page:—
1080. The expression of PS2 protein in breast cancer and it's clinical significance Page:—
1081. Expression of P16 and P15 in human gastric carcinoma and metastatic lymph node Page:—
1082. Expression of NF-Kappa B and human telomerase reverse transcriptase in gastric carcinogenesis Page:—
1083. Advances of the biological prognostic factors in breast cancer Page:—
1084. Value of intraoperative radiotherapy for adenocarcinoma gastric cardia Page:—
1085. Synergistic effects of toremifene and anti-tumor drugs on human lung cancer cell lines A549 Page:—
1086. Oxaliplation and flurouracil in combination with concurrent radiotherapy for advanced rectal cancer Page:—
1087. Correlation between CXCR4,VEGF and the blood metastasis of osteosarcoma Page:—
1088. High risk factors and management for atrial fibrillation after resection of esophageal or cardiac carcinoma Page:—
1089. Clinic analysis of the malignant probability and probable risk factor of solitary thyroid nodule in 902 cases Page:—
1090. Clinical value of infusion gemcitabine via artery port and catheter system for 37 cases with ad-vanced panceratic cancer Page:—
1091. Three-dimensional conformal radiotherapy for 56 patients with liver neoplasms Page:—
1092. Expression of CD44 level in tumor cells of esophageal carcinoma patients and its significance Page:—
1093. Effects of human lung cancer A549 cell line by FasL gene transduction Page:—
1094. Expression and prognostic significance of CD44v6 in primary gastric carcinoma Page:—
1095. Expression and significance of vascular endothelial growth factor in lung carcinoma Page:—
1096. Expression of CD44v6 protein in human breast carcinoma and its relevance for prognosis Page:—
1097. Changes in the lymphocyte subgroup after TACE, THPP of primary hepatic carcinoma Page:—
1098. Radiation-induced fibrosis in rat lung: Modification by hydroxypiperquin phosphate Page:—
1099. Recent advances in Eph receptors and Ephrin ligands Page:—
1100. Research advances in detection of carcinoma cells in peripheral blood and its clinical significance Page:—
1101. Gemcitabine and cisplatin in the treatment of advanced liver cancer Page:—
1102. Combined chemotherapy for 6 patients with spinalcord implanation medulloblatoma Page:—
1103. Serum nitric oxide level in the patients with oral squamous cell carcinoma and its change after operation Page:—
1104. Preoperative regional chemotherapy in advanced gastric carcinoma Page:—
1105. Effects of chemical splanchic denervation in reversion of T-lymphocyte subtypes level in patients suffering intractable pain with pancreatic carcinoma Page:—
1106. ~(99m)Tc-tetrofosmin SPECT for the evaluation of suspicious palpable breast lesions Page:—
1107. Hyperfractionated radiotherapy combined with chemotherapy for advanced esophageal carcinoma Page:—
1108. Expression of c-kit receptor in acute leukemia and its clinical significance Page:—
1109. Relationship between the expression of the BRCA_1 protein and clinicopathological characteristics of breast cancer Page:—
1110. Significance of NF-?B expression in human cerebral tumors Page:—
1111. Prediction of lymph node metastasis and the expression of cancer associated genes in endoscopic biopsy specimens of stomach cancer Page:—
1112. Clinical significance of vascular endothelial growth factor and p53 gene expression in human gastric cancer Page:—
1113. T lymphocyte activation associated membrane molecule expression in peripheral blood of patients with non-small-cell lung cancer and its clinical significance Page:—
1114. Advances in research on Survivin ,the inhibitor of apoptosis in cancer diagnosis and therapy Page:—
1115. Immunotherapy for cutaneous T-cell lymphoma Page:—
1116. Strategies of tumor-targeted gene therapy Page:—
1117. Gemcitabine and cisplatin combination in 32 elderly patients with non-small-cell lung cancer Page:—
1118. The study of serum vascular endothelial growth factor (VEGF) in the course of transcatheter arterial embolization of hepatocellular carcinoma Page:—
1119. Apoptosis and expression of Fas/FasL induced by daunorubicinin in human myeloid leukemia in cell line HL-60 Page:—
1120. Abnromal expression of p53,IGF-IR and PCNA in benign and malignant breast lesions of Han,Uygur woman in Xinjiang Page:—
1121. The expression of cyclooxygenase-2(COX-2) in human colorectal cancer and its clinical significance Page:—
1122. Clinical value of examination of p16 protein in lung lesions through fibrobronchoscopic brushing and biopsy Page:—
1123. Expressions of VEGF, b-FGF,NOS_2 and NOS_3 in human non-small cell lung cancer and the relationship between them and tumor angiogenesis and lymph node metastasis Page:—
1124. Detection of hMSH2 gene mutations in gynecologic tumor population by multiple PCR-SSCP Page:—
1125. CT evaluation of colorectal carcinoma correlation in operation and histopathology Page:—
1126. The results of secondary cytoreductive surgery and second-line chemotherapy for patients with epithelial ovarian cancer Page:—
1127. Efficacy and safety of epirubicin, leucovorin, 5-fluorouracil and cisplatin (ECF-L) regimen in chemotherapy for advanced gastric cancer Page:—
1128. Progress of epidermal growth factor receptor and tyrosine kinase inhibitors in the cancer therapy Page:—
1129. Advances in classification and delineation of the neck nodes in radiotherapy Page:—
1130. Nedaplatin in treating drug resistant nasopharyngeal carcinoma and non-small-cell lung cancer Page:—
1131. Clinical evaluation of intraoperative block of abdomial aorta in sacral and pelvic tumors surgical operation Page:—
1132. Expression of COX-2 and its significance in rectal familial adenomatous polyposis and rectal cancer tissues Page:—
1133. Chemosensitivity testing for human gastric cancer with short-term culture cells vs purified primary culture cells using the MTT assay Page:—
1134. Clinical characteristic,diagnosis and therapy of hereditary nonpolyposis colorectal cancer in 32 cases of 11 families Page:—
1135. Oxaliplatin,fluorouracil and calcium folinate in the treatment of patients with advanced stomach cancer Page:—
1136. Dose-escalation in non-small-cell lung cancer treatment using 3-dimensional conformal radiotherapy:preliminary results Page:—
1137. Expression of NF-?B, c-myc and ICAM-1 in colorectal cancer and its relation to the indices in clinical pathology Page:—
1138. Inhibitory effect on human stomach adenocarcinoma BGC-823 cell line of cyclin D_1 antisense oligodeoxynucleotide Page:—
1139. Expression of cyclin E, P53 protein in human gastric carcinoma and its prognostic significance Page:—
1140. Adaptation of ovarian cancer cell line SKOV-3ipl cells to hypoxia and its correlation with VEGF and Bcl-2 protein expressions Page:—
1141. MMP-7 gene expression in gastric cancer and its significance Page:—
1142. Antigenic epitopes analyses and expression of P-glycoprotein Page:—
1143. Progress in the research of tumor lymphangiogenesis Page:—
1144. The role of breast fiberoptic ductoscopy in the diagnosis of diseases with abnormal nipple discharge Page:—
1145. Analysis of the factors influencing cervical lymphatic metastasis of the floor of mouth carcinoma Page:—
1146. Expression of telomerase activity in cancer of digestive tract and its significance determined by TRAP-ELISA Page:—
1147. Surgical treatment and perioperative period management for elderly lung cancer patients Page:—
1148. Imatinib mesylate in the treatment of unresectable and/or metastatic gastrointestinal stromal tumors Page:—
1149. A study on relations of MA782 cell apoptosis induced by TAM to cyclin D1、CDK4 and TGF-?1 Page:—
1150. Roles of cyclin D1 and cyclin E in non-small-cell lung cancer and the relationship between cyclin D1 and cyclin E Page:—
1151. Effect on radiosensitivity of human lung adenocarcinoma cells transfected with wild-type p16 gene Page:—
1152. Study of correlation between early postoperative metastasis and occult micrometastasis of lymph nodes in patients with stageⅠa non-small cell lung carcinoma Page:—
1153. Effects of chemotherapy on operation for lung cancer Page:—
1154. Diagnosis and staging of lung cancer by using positron emission tomography Page:—
1155. CT value and evaluation in the TNM staging for lung cancer Page:—
1156. Development in radiotherapy for locally advanced non-small cell lung cancer Page:—
1157. Tendency of multidisciplinary cooperation in surgical treatment of lung cancer Page:—
1158. Inhibition effects of epigallocatechin-3-gallste (EGCG) on cell cycle of hum an breast cancer cells MDA-MB-435 and its mechanism Page:—
1159. Clinical trial of letrozole for postmenopausal patients with bone metastasis in breast cancer Page:—
1160. Relationship between cell apoptosis and dephosphorylated RB protein in human breast cancer Page:—
1161. Combined management of non-small cell lung cancer:current status and perspective Page:—
1162. The cytotoxic effect,cell cycle perturbations and apoptosis of paclitaxel in human bladder cancer lines Page:—
1163. Relapse or disease-free survival rate prediction value of TIP30 protein expression in NSCLC Page:—
1164. Expression of epidermal growth factor receptor,vascular endothelial growth factor receptor and BAD in non-small-cell lung cancer Page:—
1165. The changes of mRNA expression of telomerase subunits induced by Ara-C in HL-60 cells Page:—
1166. Expression of chemokine receptor CXCR4 in hypopharyngeal carcinoma and its significance Page:—
1167. Advance in the study on the clinical characteristics,diagnosis and therapy for primary lung cancer in young patients Page:—
1168. Advance on stereotactic radiotherapy for early stage non-small cell lung cancer Page:—
1169. Clinical efficacy of surgical therapy in patients with advanced gastric cancer after pre-operative neoajnvant chemotherapy Page:—
1170. Efficacy of neoadjuvant chemotherapy with antracyclines plus paclitaxel or docetaxel regimen in stageⅢbreast cancer patients Page:—
1171. Clinical analysis of treatment outcome for 559 patients with endometrial cancer Page:—
1172. Clinicopathologic features,surgical methods and prognosis in peripheral<2 cm(of diameter) non-small cell lung cancer Page:—
1173. A randomized controlled study of Shenfu injection combined vinorelbine chemotherapy on the quality of life of elderly non-small cell lung cancer patients Page:—
1174. Efficacy of calf spleen extraction injection combined chemotherapy in the treatment of advanced nonsmall cell lung cancer Page:—
1175. Chromosomal analysis of lung cancer by comparative genomic hybridization Page:—
1176. Expressions of MG7 in tissue and serum in cancerization risk prediction of gastric precancerosis and its clinical significance Page:—
1177. NK/T cell infiltration and prognosis in primary squamous cell carcinoma of the lung Page:—
1178. Promotion of invasion and metastasis in human breast carcinoma MCF-7 by SDF-1? Page:—
1179. Expression and correlation of p27 and survivin in NSCLC Page:—
1180. Expression of tyrosine kinase receptor B in OVCAR-3 ovarian cancer cells and its significance Page:—
1181. The role of GSK-3?in apoptosis induced by proteasome inhibitors combined with paclitaxel in ovarian cancer cells and its possible mechanism Page:—
1182. An oncosis-like cell death of pancreatic cancer Panc-1 cells induced by artesunate is related to generation of reactive oxygen species Page:—
1183. Advance of the tumor therapy based on hypoxia-inducing factor inhibitors Page:—
1184. Her-2/neu gene and radiosensitivity Page:—
1185. Advances in research on relationship between Hedgehog signal pathway and gastroenteric tumor Page:—
1186. Analgeic effect of patient control subcutaneous morphine combined with small-dose ketamine on moderate/severe terminal cancer pain Page:—
1187. Clinical study on ibandronate combined with chemotherapy in treatment of lung cancer with bone metastasis Page:—
1188. Effect of LY294002 and its combination with chemotherapy drugs on the proliferation of human leukemia K562 cell line and its possible mechanism Page:—
1189. MEK inhibitor improves the epirubicin sensitivity of breast carcinoma cell line MCF-7 Page:—
1190. Effect of chemoinducible GM-CSF gene expression regulated by Egr-1 promoter on chemotherapy damage of tumor bearing mice Page:—
1191. Study of Helicobacterpylori on p38MAPK signal transduction pathway activation in gastric epithelial cancer cells line MKN45 Page:—
1192. Clinical features and multimodality treatment of 11 cases with small-cell esophageal carcinoma Page:—
1193. Preventive effect of hepatic arterial infusion (DDS) against post-operative recurrence of hepato-cellular carcinoma Page:—